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Abbreviations
The following abbreviations are used in  the text.
br broad
DIBAL diisobutylaluminium hydride
DMSO dimethylsulfoxide
HMG 3-hydroxy-3-m ethylglutaric acid
Hz hertz
IR infrared
m multiplet
MHz megahertz
MS mass spectrum
NMR nuclear magnetic resonance
NOE nuclear overhauser effect
q quartet
s singlet
t triplet
THF tetrahydrofuran
TLC thin layer chrom atography
Notes on  N om enclatu re
Pyrrolizidine compounds with one or two double bonds are 
nam ed as derivatives of 1H- o r 3 /fpyrro lizine in agreem ent with 
Chemical Abstracts nom enclature, e.g. ethyl 5,6,7,§-tetrahydro-3H- 
ethyl pyrrolizine-l-carboxylate.
Fully saturated compounds are nam ed as pyrrolizidine 
derivatives. The stereochem istry of substituents is indicated by the 
a and |3 nomenclature.
For macrocyclic diester alkaloids, the num bering scheme 
proposed by Culvenor et al. is used (C.CJ. Culvenor, D.H.G. Crout, W. 
Klyne, W.P. Mose, J.D. Renwick, and P.H. Scopes, J. Chem. Soc. (C), 
1971. 3653). For example, the num bering system as applied to 
senecionine is shown.
CQ>Et
6
5 4 3
18
5 4 3
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SUMMARY
The work presented in this thesis is concerned with the 
biosynthesis of the necic acid portions of pyrrolizidine alkaloids and 
has been divided into five main areas: (a) the development of a 
general route to a variety of i3C- and 2H- labelled isoleucines; (b) 
the synthesis of a specifically labelled isoleucine; (c) the synthesis of 
labelled 2 -aminobutanoic acid; (d) feeding experiments with plants 
and transform ed root cultures which produce pyrrolizidine alkaloids; 
(e) the synthesis of new and known synthanecines for biosynthetic 
studies and investigation of their anti-tum our activity.
(a) D evelopm ent o f a  G eneral Route to Isoleucine
Isoleucine has been shown to be specifically incorporated into the 
acid portions of several pyrrolizidine alkaloids. Some acids with ten 
carbon atoms are form ed from two isoleucine units. In the 
development of a synthetic route to isoleucine it would be desirable 
to assemble the target com pound by the stepwise addition of one 
and two carbon units. This would allow the same route to furnish a 
range of isoleucines, isotopically labelled with 2H or 13C at different 
positions. We decided to modify a published route to valine. 
However this synthesis required m any stages, a  few of which were 
low yielding, making this scheme uneconomic as an all-purpose 
route to labelled isoleucines. DL-[6 -2H3]Isoleucine hydrochloride (A) 
together with the allo-racemate was the only labelled amino acid 
prepared using this procedure.
(ix)
RO CH3
CIH3N ^
(C)
c o 2h
(B) R = H 
(F) R = Ac
(b) Synthesis of a Specifically  Labelled Iso leucine
In the biosynthesis of the acid portion of dicrotaline (B) in 
Crotalaria lachnosema, isoleucine labels four out of the six carbons. A 
route was developed to [3-2H]isoleucine hydrochloride (C) and the 
allo-racemate in an  attem pt to discover which of the two m ethylene 
groups of 3-hydroxy-3-methylglutaric acid is provided by 
isoleucine.
(c) Synthesis of Labelled 2-A m inobutanoic ac id
2-Aminobutanoic acid is also a  biosynthetic precursor to several 
necic acids. A short synthesis of this precursor from diethyl 
acetamidomalonate was developed from literature procedures. 
Samples of DL-[3, 4 -^  C?]-2-aminobutanoic acid hydrochloride (D) 
and DL-[3,4-2Hs]-2-aminobutanoic acid (E) were made.
M
18
HQ
(D) * 13< - -  OH
* — D3C CD2
(G)
(d) Feeding E xperim ents
Feeding experiments were carried out on two plants, Senecio 
pleistocephalus and Crotalaria lachnosema, and on two transform ed 
root cultures, Senecio vulgaris and Emilia flam m ea . C. lachnosema 
produces dicrotaline (B) and 13-O-acetyldicrotaline (F). The crude 
alkaloid mixture isolated from  this plant was converted wholly into 
13-O-acetyldicrotaline, and  a full and 13C NMR assignment and 
conformational analysis of this com pound (F) were performed. 
However all feeding experiments on this p lant species failed to show 
any incorporation of stable isotopes into the alkaloid above natural 
abundance.
Successful feeding experiments were carried out with S. 
pleistocephalus which produces rosmarinine (G). Deuterium (E) and 
i3c-13C doubly labelled 2-aminobutanoic acid (D) were incorporated 
into rosm arinine (G) labelling two pairs of carbon atoms, namely C- 
13 and C-19 plus the C-20 and C-21 positions and equal labelling 
was observed in both halves of the acid portion. Senecionine (H) 
from S. vulgaris was also labelled after feeding experiments with 2- 
aminobutanoic acid. Again the C-13 and C-19 plus C-20 and C-21
positions were labelled with the amino acid incorporated into both 
halves of the necic acid equally.
The root culture E. flammea  produces two alkaloids, senecionine 
(H) and emiline (I). However in the feeding experiment with 2- 
aminobutanoic acid, only senecionine and a small am ount of its 
geometrical isomer integerrim ine (J) were observed. The labelling 
patterns for senecionine were the same as previously observed with 
m aterial isolated from S. vulgaris.
HQ
HO,O
CH2
M e
(I)
(e) Form ation  of S yn thanecines
Synthanecine A (K) and synthanecine B (L) were prepared using 
known procedures. These synthanecines were fed to S. vulgaris root 
cultures, but no new alkaloid analogues could be detected. The use 
of 1,3-dipolar cycloaddition reactions was investigated as a m ethod 
for the m anufacture of synthanecines. The use of trimethylamine N- 
oxide (M) and lithium  diisopropylamide with a  variety of alkenes 
proved unsuccessful. In an alternative procedure ALbenzyl-AL 
(trimethylsilylmethyl)aminomethyl m ethylether (N) did undergo the 
desired cycloaddition with diethyl fum arate, and the product was 
subsequently converted into a novel synthanecine (O).
(x i i)
MeN
,CH2OH
ch2oh
MeN
,CH2OH
(K)
MesSi'
Me3N  O
(M)
‘N‘
CH2Ph
(N)
‘OCH3
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PhCH2N
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(xiii)
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CHAPTER 1
In tro d u c tio n
1.1 P y rro liz id in e  A lkaloids
Pyrrolizidine alkaloids are secondary metabolites produced 
by certain higher plants, and they make up a  large and 
interesting area of natural product chem istry . 1 There have been 
m any studies into the synthesis and biosynthesis of these 
alkaloids. The toxicology of pyrrohzidine alkaloids has aiso been 
extensively investigated . 2
The widespread occurrence of pyrrohzidine alkaloids is weh 
docum ented and they have been found in 14 unrelated plant 
families.3 Over 200 different alkaloids have been isolated and 
identified from over 300 plant species .4  It has been estim ated 
that approximately 3% of the world's flowering plants contain 
pyrrohzidine alkaloids. 5 The plant families studied include 
Asteraceae (formerly Compositae), e.g. tribes Senecioneae and 
Eupatorieae, and Fabaceae (formerly Leguminosae) of which the 
genus Crotalaria is the only one known to produce pyrrohzidine 
alkaloids.
Most pyrrohzidine alkaloids are derivatives of 1- 
hydroxymethylpyrrohzidine (1 ), ra ther than  of pyrrohzidine (2 ) 
itself. They are comprised of an acid portion (necic acid) and a 
base portion, called a necine. A wide range of necines has been 
identified, differing in the degree of hydroxylation and the 
positions and stereochemistry of the hydroxyl groups, e.g.
1
rosmarinecine (3). Another im portant variation is the 1,2- 
unsaturation, shown here in retronecine (4).
CH2OH
(1)
OH
-  -  OH
(2)
OH
(4)
The esterifying acids are branched chain mono- o r di- 
carboxylic acids. They vary in degree of chain branching, 
hydroxylation and unsaturation. The alkaloids can be monoesters 
e.g. viridiflorine (5); diesters, like symlandine (6 ); or macrocyclic 
diesters, as retrorsine (7).
2
Me Me
HQ
Me
HQ
O Me
OH
(5) (7)
OH
Me
Me
(6)
OH
/
C
Meg
CHOH
Me
1.2 Effects o f P y rro liz id ine A lkaloids on  H um ans an d  
A n im als
The importance of pyrrolizidine alkaloids is due to their wide 
spectrum of biological action .3 Alkaloids with 1,2-unsaturation 
are hepatotoxic3 and there have been m any instances of the 
poisoning of both livestock and humans. Indeed ragworts are 
said to have caused more livestock losses than  any other 
poisonous plant species.6
3
As early as 1787, British farmers suspected tha t the common 
ragw ort, Senecio jacobaea, was harm fu l to grazing cattle. 
Ingestion of pyrrolizidine alkaloids has either been by deliberate 
use or by mistake for o ther species. Some herbal rem edies or 
foods are plants containing pyrrolizidine alkaloids, for example 
comfrey (Sym phytum  sp .).
In South Africa seeds of Senecio ilicifo lius  and Senecio 
burchelli were harvested with the wheat, resulting in bread  
poisoning7 an d  one of the m ost serious exam ples was in 
Afghanistan in 1974 when around 1600 people were affected by 
abdom inal distension and emaciation resulting in many deaths .8
The m ain target organ of pyrrolizidine alkaloids is the liver 
b u t the lungs, kidneys and  the h ea rt may also be affected. 
Although other organic compounds are known to be toxic to liver 
cells, e.g. halogenated hydrocarbons and dialkylnitrosoamines. 
The p rogressive an d  irreversib le  ch ron ic  liver dam age, 
illustrated by inhibition of cell division and megalocytosis of the 
liver is diagnostic for pyrrolizidine alkaloid poisoning.
Some species can use py rro liz id ine  alkalo ids to th e ir  
advantage. Various butterflies (Lepidoptera) feed on plants 
containing alkaloids and store the alkaloids as a defence against 
p red a to rs . 9 It is also known th a t some butterflies convert the 
alkaloids in to  volatile aldehydes or ketones w hich act as 
pheromones .10
1.3 M etabolism  an d  Cytotoxicity
There are three main routes for metabolism of pyrrolizidine 
alkaloids. These are ester hydrolysis and N-oxidation, which are
4
detoxification pathways that produce water soluble species 
which can be excreted, and dehydrogenation. It is the 
dehydrogenation pathway which leads to the cytotoxicity.
The fact that liver damage is the m ain effect of pyrrolizidine 
alkaloid poisoning, regardless of the site of adm inistration , 11 
indicates that it is the metabolites ra ther than  the alkaloids 
which are toxic. The liver is the organ where pyrrolizidine 
alkaloid metabolism occurs. Hepatic microsomal enzymes oxidise 
those alkaloids which contain 1 ,2 -unsaturation to pyrrolic 
intermediates (Scheme 1). Cytochrome P450 is the major enzyme 
catalysing pyrrole form ation12 producing highly reactive species 
compared to the chemically unreactive alkaloids. The pyrrole 
formation is proposed to be via oxidation at C-8 .
Toxicology studies by Mattocks13 have shown th a t there is a 
direct relationship between the am ounts of pyrrolic metabolites 
found in rat livers and acute hepatotoxicity. The toxic action of 
the pyrroles is associated with alkylation processes due to the 
activation of the ester functions by the n itrogen14 (Scheme 1).
5
Scheme 1
OCOR*
OCOR
enzyme
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OCOR
DNA
OCOR'
DNA
OCOR'
OCOR
OH
OCOR'
OCOR
H
OCOR'
DNA
I
The pyrrolic metabolites form ed from pyrrolizidine alkaloids 
can have one o r two reactive ester sites o r one ester function 
and a  less reactive hydroxyl group. They can, therefore, act as
6
bifunctional alkylating agents when they are attacked by 
nucleophilic sites of DNA, resulting in  crosslinking15 (Scheme 1).
Pyrrolizidine alkaloids containing saturated necines are not 
cytotoxic. Although they are also metabolised to pyrrolic 
species, these are different to those formed by hepatotoxic 
pyrrolizidine alkaloids. Mattocks and White investigated the 
pyrrolic species formed from  rosm arinine15 (8 ) and  found tha t it 
is the left hand ring which is converted into the pyrrole (Scheme 
2). This produces a metabolite (9) which does not have an ester 
group activated by the nitrogen and hence cannot act as an 
alkylating agent.
Scheme 2
HQ HQ
CQ>H
enzyme
- -  OH - - OH
(8)
1.4 S tru c tu re  A ctiv ity  R elationsh ips
The toxicity of pyrrolizidine alkaloids is closely associated 
with their structures. Schoental observed that all known 
hepatotoxic alkaloids were esters of retronecine (4), supinidine 
( 1 0 ) or heliotridine (1 1 ) and concluded that the 1 ,2 -unsaturation
7
was necessary . 16 This agreed with the findings of Grebenuik and 
Zaharova, who observed that platyphylline (12), which does not 
possess the allylic ester function, produced no trace of liver 
damage in dogs. 17 Subsequently, Culvenor e t al. proposed the 
mechanism shown in Scheme l . 18
OH
(4) ( 10)
OH CH2OH
(H)
HQ
(12)
Lipophilicity and base strength of the alkaloid are two factors 
which affect toxicity .2 Higher lipophilicity means that the 
alkaloids are more susceptible to oxidation by hepatic 
microsomal enzymes, and  hence are more toxic. Alkaloids of 
higher base strength are usually less lipophilic and therefore less 
toxic. The reduced toxicity is due to the fact that proportionally 
more of the alkaloid is protonated at physiological pH and thus 
can be excreted.
8
The ester hydrolysis detoxification pathway is less favourable 
if access to the esters is restricted. For example bulky 
substituents at the oc-carbon of the acid will increase the toxicity 
due to steric hindrance of the hydrolysis. 19>20
1.5 C linical Uses o f P yrro liz id ine A lkaloids
Pyrrolizidine alkaloids have also been studied for anticancer 
activity. Two mechanisms are possible for anti-tum our activity: 
(i) anti-mitotic effect of pyrrolic metabolites; and (ii) an 
unknown mechanism involving N-oxides. In the USA indicine N- 
oxide (13) has undergone clinical trials as an  anti-cancer agent21 
and platyphylline22 ( 1 2 ), which has the benefit of not being 
hepatotoxic, has been examined for antispasmodic and mydriatic 
affects.
9
HQ
CH3
( 12)
OH
OH
HO
0
(13)
Further inform ation on pyrrolizidine alkaloids is available in 
the books by Mattocks, 2 and by Bull e t  a / .,1 and in annual 
reviews .23
1.6 Aims o f P roject
The biosynthesis of pyrrolizidine alkaloids has been a t the 
centre of a trem endous am ount of research in our group .24  This 
work and the work of others is reviewed in Chapter 2. The 
biosynthetic pathways to necines are now well established and 
m any of the interm ediates have been identified. However the 
biosynthesis of the necic acids is not so clear. Mevalonate and
10
acetate have been shown not to be precursors .25*26  Work by 
Crout27’28 identified the specific incorporation of a-amino acids 
into the acid portions of some of the alkaloids. All previous 
investigations of necic acid biosynthesis have involved 
radiotracers. Our intention was to provide the first study of the 
biosynthetic pathways to the necic acids using stable isotopes. 
The attem pts to develop a  general route to a range of labelled 
isoleucines (14) are described in Chapter 3.
Isoleucine has been shown to be a  precursor for 3-hydroxy-
3-methylglutaric acid (15), the acid portion of dicrotaline (16) 
which is produced, along with 13-Oacetyldicrotaline (18), by 
Crotalaria lachnosema. In order to investigate the biosynthesis of 
this necic acid a specifically labelled isoleucine was required. 
The synthesis of this amino acid is detailed in Chapter 4.
c q >h
(14)
11
RQ
HO,
(17)(15)
(16) R=H 
(18) R=Ac
2-Aminobutanoic acid is another known precursor of some 
necic acids. The formation of 2H- and ^ C -d o u b ly  labelled 2- 
aminobutanoic acid (17) and the feeding experiments 
perform ed are described in Chapter 5.
To examine the biosynthesis of pyrrolizidine alkaloids using 
stable isotopes the NMR spectral analysis of the alkaloids under 
study is required. The conformational analysis and NMR 
assignments perform ed on 13-O-acetyldicrotaline (18) are 
described in Chapter 6 .
Chapter 7 is concerned with the synthesis of novel and known 
synthanecines, which are analogues of naturally occurring 
necines. These synthetic analogues are simpler to prepare than 
the corresponding pyrrolizidine bases and have been used in 
toxicology studies. Synthanecines A (19) and B (20) were 
prepared by known m ethods for feeding experiments, in an 
attem pt to form new alkaloid analogues. The synthesis of new 
synthanecines using dipolar cycloaddition reactions was
12
investigated in order to provide material for tests of possible 
anticancer activity.
CHpOH
MeN
(19)
MeN
CH2OH
CH2OH
(20)
13
CHAPTER 2
Biosynthesis of Pyrrolizidine Alkaloids
2.1 Biosynthesis of Necine Bases
The study of the biosynthesis of necines began over 30 years ago 
when Nowacki and Byerrum20 used Crotalaria spectabilis to examine 
the pathway to monocrotaline (21). These initial experiments 
demonstrated the incorporation of ornithine (2 2 ) into the base 
portion retronecine (4). Similar results were observed by Warren 
and co-workers30 with feeding experiments using Senecio isatideus 
and S. sceleratus.
Retronecine (4) is the base portion of all the alkaloids produced 
from Senecio douglasii. Bottomley et a\$ l fed 14C labelled ornithines 
to this species, which were incorporated to a reasonable extent (0.3- 
0.75%), and approximately 94% of the activity was located in the 
base portion. The retronecine (4) obtained was subjected to further 
degradation with osmium tetroxide and sodium periodate, liberating
n a  ch^ o ch3
OH
(22)
(21)
14
formaldehyde (23) which was trapped as the dimedone derivative 
(Scheme 3).
Scheme 3
OH 9CH20H
7
,c o 2h
6 9
HCHO6
5 \ N /  NalO.'4
5 4  3
(31) (23)
This corresponds to C-9 of retronecine and, after feeding [2- 
14C]omithine and [5-14C]omithine to S. douglasii, 25% of the base 
portion activity was found in the formaldehyde dimedone. This 
suggested that C-2 and C-5 of ornithine become equivalent, possibly 
by decarboxylation to putrescine (24). When Bottomley and 
Geismann31 investigated this possibility, they found that [1,4- 
i4C]putrescine was incorporated fairly well (0.18%) into the alkaloids 
produced by S. douglasii, with 98% of the activity in the base portion. 
Again 25% of this radioactivity was found in the formaldehyde 
dimedone derivative.
Bale and Crout observed the incorporation of arginine (25) into 
senecionine (26) in Senecio magnificus 32 Due to erratic results with 
plants growing under hydroponic conditions, they developed a
H CQ>H 
(25)(24) (26)
15
double isotope technique, measuring the ratio of 3H /14C isotopes in 
the precursor compared to the final alkaloid. Feeding L-[3- 
3H] arginine and L-[U-14C]arginine (initial ratio 4.84) to S. magnificus 
yielded senecionine (26) with an average 3H /14C ratio of 3.0. 
Experiments with L-[3-3H] arginine and L-[U-14C]omithine showed a 
fall in the 3H /14C ratio in the resulting senecionine samples, 
indicating that ornithine is a more efficient precursor than arginine 
for retronecine in S. magnificus,32
nh5 nh2 NH(CH2)3NH2
,NH(CH2)3NH2 .NH(CH2)3NH2
(27) (28) (29)
A better technique for carrying out feeding experiments was 
devised by Robins and Sweeney33 By dropping aqueous solutions of 
the precursors on the stems of the plant and puncturing the stems, 
large incorporations were obtained for [l,4 -14C]putrescine (27), [1,4- 
14C]spermidine (28) and [l,4-l4C]spermine (29) into retrorsine (30) 
with Senecio isatideus. Using the degradation techniques previously 
described (Scheme 3), 25% of the activity was found in the dimedone 
derivative and 25% of the activity was found in the p-alanine (31). 
This suggested that two molecules of putrescine combine to give 
retronecine (4) , with spermine (32) and spermidine (33) probably 
acting as a source of putrescine.
16
H2N(CH2)3NH(CH,)4NH(CH2)3NH2
H2N(CH2)3NH(C^kNH2
(32)
(33)
HQ , ,CH2 °H
O
(30)
Hartmann and c o - w o r k e r s 3 4  reported that putrescine (24) was 
formed only from arginine (25) in Senecio vulgaris, while Birecka et 
al. found that putrescine is formed from arginine in Heliotropium 
s p e c ie s 3 5  but in Senecio and Crotalaria species it is ornithine that is 
converted into p u t r e s c i n e 36. The contradiction of the origin of 
putrescine in Senecio species has not yet been resolved.
The lack of suitable degradations meant that complete labelling 
patterns were impossible to obtain with radiotracers. Using stable 
isotopes, complete labelling patterns can be determined by NMR 
spectroscopy. Khan and R o b in s 3^ prepared [ 1,4- ^ CzJputrescine 
dihydrochloride (34) from 1,2-dibromoethane (35), and fed it to 
Senecio isatideus (Scheme 4). Enrichment of the C-3, C-5, 0 8  and 0 9  
positions of retronecine (4) was observed. This result verified that 
two molecules of putrescine combine in the biosynthesis of 
retronecine.
17
Scheme 4 
Br
k 13c n
CN
1. BH3 .THF
2. HC1
NH3 CI
NH3 CI
Br 
(35)
CN
OH
(34)
OH OH
+ +
*
Use of this precursor led to broadening of the signals in the 13C 
NMR spectrum due to 13c-N-13C and 13C-C-13C species. Therefore [1- 
i3C]putrescine (36) dihydrochloride was synthesised from N- 
protected 3-bromopropylamine (37). The retronecine produced by 
feeding to S. isatideus showed approximately 100% enhancement of 
the C-3, C-5, C-8  and C-9 positions of retronecine (38) (Scheme 5).
Scheme 5
Br
k 13c n
*
CN
,NHCQ2CH2Ph
(37)
,NH2C02CH2Ph
+
-NH3CI
+
-NH3 CI
(36)
Composite drawing 
showing all labelled 
positions
OH
(38)
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The 13C labelling patterns obtained in some experiments with [1- 
13C]putrescine dihydrochloride were not easy to establish, as the 
enhancements were difficult to measure and the conditions had to be 
carefully controlled to limit the amount of unlabelled material 
present. A more effective method is to use I3c-l3c doubly labelled 
precursors resulting in pairs of doublets around the natural 
abundance 13C signal in the alkaloid.
Khan and R o b in s  37 used the procedure described in Scheme 4 to 
synthesis [2 ,3 -13C2]putrescine dihydrochloride (39). After feeding 
this precursor to S. isatideus the retronecine hydrochloride (40) 
sample had two pairs of doublets of approximately equal intensity, 
corresponding to C-l and C-2 and the C-6  and C-7 positions, with 
coupling constants of 71 and 34 Hz, respectively (Scheme 6 ).
Scheme 6
OH
(40)(39)
Robins also prepared [1,2-13C2]putrescine dihydrochloride (41) as 
shown in Scheme 7.38 [l^-^C zH ^-D ibrom oethane (42) was 
converted into the mono- N-phthalimide derivative (43), and the 
other bromine was displaced with ethyl cyanoacetate. The ester 
function was removed, the nitrile was reduced and the phthalimide 
was hydrolysed to give the doubly labelled putrescine hydrochloride 
(41). Incorporation studies with S. isatideus gave retronecine (44) 
containing four pairs of doublets in the 13c NMR spectrum with 
different coupling constants (Scheme 7).
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Scheme 7
Br Br
K phthalimide Et02 CCH2CN
CN
V  acetone \
NPhth
(42) (43)
OH CH2OH
NaH, DMF
NPhth
NaCl, DMSO 
H2 0 , 165°C
NH3CI
NH3 CI
+
+
1. P t0 2, AcOH
<-------
2. HC1
CN
NPWV\
(44) (41)
Composite labelling pattern
All the evidence indicated that two putrescine molecules form 
the necine via a later sym m etrical interm ediate. To determ ine 
which C-N bonds remain intact in retronecine, Robins and Khan39 
used the route described in Scheme 5 to prepare 13C-15N labelled 
putrescine (45). The 13C NMR spectrum  of the biosynthetically 
enriched retronecine (46) showed two doublets around the C-3 
and  C-5 positions of equal intensity. The asterisks indicate the 
enriched  positions. This agreed w ith sim ilar experim ents by 
Grue-Sorensen and Spenser4 0  w ith retronecine (46) obtained 
from Senecio vulgaris (Scheme 8 ).
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Scheme 8  
.Br
13C15n
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NH3 CI
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(45)
OH
OH
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(46)
J
This is further evidence that there is a C4-N-C4  symmetrical
intermediate produced during the biosynthesis of retronecine.
The identity of the C4-N-C4  intermediate seemed likely to be N-(4-
aminobutyl)-l,4-diaminobutane (homospermidine) (47), which has
been found in other plants.41
nh2
n h 2
(47)
Khan and Robins42 prepared [l,9-14C]homospermidine 
trihydrochloride (48) from Nr protected 4-aminobutanoic acid (49) 
and 3-bromopropylamine (50) via the mixed anhydride method 
(Scheme 9). The radiolabel was introduced by 14C-cyanide 
displacement of bromine. Removal of the protecting group, reduction 
of the nitrile and amide, and acidification gave the labelled
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homospermidine trihydrochloride (48). The precursor was 
incorporated (0.5%) into retrorsine which was hydrolysed to 
retronecine (51) which contained most of the radioactivity. After the 
degradations described earlier were carried out (Scheme 3), 44% of 
the activity was found to be at the C-9 position and virtually none in 
the C-(5+6+7) fragment, consistent with the labelling pattern shown 
(51).
Scheme 9 
NHCCfeCHgPh
+
NHCOgCHgPh
Br>
PhCOCl
COfeH
(49) (50) KI4CN
NH3CI
NHCOjjCHaPh
/
*
CN
(48)
OH
OH
(51)
O
^ > = 0
.CQ>H
NH2
[4,6-14C]Homospermidine trihydrochloride (52) was also prepared 
by Khan and R o b in s 42 and was incorporated into retrorsine (0.7%). 
The alkaloid was hydrolysed to retronecine (53) containg most of the 
radioactivity and, after carrying out the degradations previously 
described, 46% of the activity was located in the C-(5+6+7) fragment
22
(54), with little being found in the C-9 position of retronecine. This
agrees with the labelling pattern (53) proposed (Scheme 10).
Scheme IQ
NH3CI
(52)
OH
(53)
t
HQ>C nh2
:0
(54) h
Khan and R o b i n s 4 2  proved the intermediacy of homospermidine 
(47) with an intermediate trapping experiment. DL-[5-14C]Omithine
(55) was fed to S. isatideus, and the plant was extracted after one 
day and inactive homospermidine was added to the extract. The 
extract was derivatised with isothiocyanatobenzene (56) and the 
derivative (57) was recrystallised to constant activity (0.5% of the 
precursor activity). This proves that homospermidine (47) is present 
in the plant and can be formed from ornithine (22). Birecka et al.43 
have also identified homospermidine in Heliotropium indicum.
nh2
H
NH2
c o 2h
(55)
PhNCS
(56)
NHCSNHPh
CSNHPh
.N.
(57)
/ NHCSNHPh
Studies with stable isotopes have also supported the role of 
homospermidine (47) as a precursor to necines. [1,9-
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Homospermidine trihydrochloride (58) was prepared from 1-
bromo-3-chloropropane (59) by Rana and Robins44 (Scheme 11). 
Scheme 11
™  ^  KI3CN n PhClTNH,
Br (CH2 )3 C1---------- ►  Cl (CH2 ) 3  13CN------- CH^
.N .2
*
,CN
*
CN
-A .
\
(59)
NH3CI
n h 3c F
h2ci
,N.
+
(58)
The precursor was fed to S. isatideus and retrorsine was 
extracted. The 13C NMR spectroscopic analysis on the alkaloid 
showed doublets of approximately equal intensity around the signals 
for C-8  and C-9. The geminal coupling constant of 6  Hz and lack of 
any other enriched signals proves that homospermidine is 
incorporated intact into retronecine.
Kelly and Robins prepared [1 ,9 - 13C2] homospermidine 
trhydrochloride (58) and fed it to Senecio pleistocephalus and 
observed about 100% enrichment of C-8  and C-9 of rosmarinine
(59)45
The formation of homospermidine from putrescine could involve 
three possible known enzymes: (a) diamine oxidase; (b) diamine 
transaminase; or (c) homospermidine synthase. Hartmann and co­
workers have isolated (c) from root cultures of S. vulgaris and 
Eupatorium c a n n a b in u m They also eliminated the possibility of 
diamine oxidase and diamine transaminase being involved in the 
formation of homospermidine (47), and demonstrated that 1-
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pyrroline (60) is not an intermediate in the formation of 
homospermidine (Scheme 12).
(60)
N
Scheme 12
H2N‘
h2n . NAD+ 
NADH + H+
(47)
It is likely, however, that diamine oxidases are involved in the 
formation of the pyrrolizidine ring system from homospermidine. 
R o b in s4 7  demonstrated that this was possible by incubating 
homospermidine with pea seedling diamine oxidase. After one week, 
reduction of the mixture by enzymic or chemical means yielded 
trachelanthamidine (61), showing that conversion of 
homospermidine into 1-hydroxymethylpyrrolizidine (1 ) is possible 
under physiological conditions. The likely pathway is shown in 
Scheme 13.
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and 4 . 5 %  respectively). The 3 H / 14C  ratios of the precursor compared 
to the alkaloid decreased in both experiments, indicating that the 
iminium ion is incorporated more efficiently than putrescine.
The iminium ion was also shown to be formed from putrescine in 
S. pleistocephalus by an intermediate trapping experiment, 
performed by Kelly and Robins.48 One day after feeding [ 1 , 4 -  
14C]putrescine dihydrochloride to one plant, extraction of the amines, 
reduction of the mixture with sodium borohydride and reaction with 
isothiocyanatobenzene (56), gave the derivative (66) which was 
recrystallised and shown to contain 0 . 4 %  of the activity fed.
NHCSNHPh
(66)
The intermediacy of the iminium ion (62) has also been 
demonstrated for heliotridine in Cynoglossum officinale, and for (+) 
isoretronecenol (67) and (+) supinidine (68) from C. australe,49
c h 2oh
(67) (68)
Kunec and Robins prepared 3H-labelled 1- 
hydroxymethylpyrrolizidines (69), (70) (Scheme 15), starting from 
L-[5-3H]-proline (71).50
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Scheme 15
1.HC02 H/ Ao>0
2 . A c 20  ^  
H C = C C 0 2Et
NH
(73)(72)
(71) 1.HC1
2. EtOH/ H LiAlH
(70) (74) (69)
The proline (71) was N-formylated, and then the product underwent 
a 1,3-dipolar cycloaddition with ethyl propiolate. Hydrogenation of 
the pyrrole (72) gave the endo-pyrrolizidine ester (73), which was 
treated with lithium aluminium hydride to give [5- 
3H]isoretronecacanol (69). [5-3H]Trachelanthamidine (70) was 
prepared by epimerisation of the endo-ester (74), under acidic 
conditions, to the exo-acid which is thermodynamically more stable, 
then re-esterified. Reduction gave the 3H- labelled precursor (70).
Various feeding experiments showed that trachelanthamidine
(61) is a good precursor for retronecine (4) and heliotridine (11) but 
isoretronecanol (75) was incorporated far better into rosmarinine 
(8).50, 51 Leete and Rana52 also demonstrated the incorporation of 
trachelanthamidine into riddelline (76) in Senecio riddelli.
[5-3H] Isoretronecanol (69) has also been shown to be 
incorporated well into cynaustraline (77) and cynaustine (78) in 
Cynoglossum australe, but trachelanthamidine (61) showed no 
incorporation into these alkaloids.53 Hagan and Robins obtained
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radioactive samples of (+)-isoretronecanol (67) and (+)-supinidine 
(68) by feeding [l,4-3H]putrescine dihydrochloride to C. australe.53 
In turn, feeding experiments showed that (+)-isoretronecanol (67) is 
incorporated is incorporated into cynaustraline (77) and cynaustine 
(78) but (+)-supinidine (68) is incorporated only into cynaustine
These results suggest that the biosynthetic pathway diverges in 
the formation of the necine bases. (+)-Supinidine (68) is formed from 
isoretronecanol after the pathway has split.
(78).
Me Me
HQ CH2OH
c h 2o h  o
O OH OH
Me
(75) (76) (77)
Mev Me
V h
Me
O OH OHt
OH CH2OH
Another common base portion of pyrrolizidine alkaloids is 
otonecine (79), present in senkirkine (80), emiline (81) and 
syneilesine (82). Hartmann and co-workers54 observed that the 
amount of senkirkine present in Senecio vemalis root cultures 
increased as the amounts of senecionine N-oxide (83) present 
decreased. Robins and co-workers showed that putrescine (24), 
homospermidine (47), the iminium ion (62), trachelanthamidine (61) 
and retronecine (4) were all precursors to otonecine (79).55 The C-8 
to N-4 band must be broken late in the biosynthetic pathway, 
possibly after hydroxylation at C-8 and methylation of the nitrogen, 
allowing cleavage of the bicyclic ring (Scheme 16).
OH
ch2Me
Me
(81)
Me
(80)
OH
Me Me
Me
(82)0_
(83)
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As a result of the comprehensive studies of necine biosynthesis 
the pathways have been established. These are shown in Scheme 17 
with the known intermediates in boxes. L-Omithine (22) undergoes 
decarboxylation to putrescine (24). Homospermidine synthase 
oxidises one of the primary aldehyde groups of putrescine to the 
aldehyde, which combines with another molecule of putrescine to 
give the imine (84), which is reduced to homospermidine (47). 
Oxidation of a primary amine function of homospermidine, again 
yields an aldehyde which undergoes cyclisation to the iminium ion
(62). The remaining primary aldehyde is oxidised to the aldehyde 
and this iminium ion can undergo cyclisation to give either 
isoretronecanol (75) or trachelanthamidine (61). Hydroxylation of 
trachelanthamidine and elimination forms retronecine (4) and 
heliotridine (11). Otonecine (79) can be formed from retronecine (4) 
as previously described.
31
Scheme 17
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The stereochemistry of the biosynthesis of necines has also been 
investigated. Firstly Robins found that only the L-isomers of 
ornithine (22) and arginine (25) are precursors of necines,56 and 
several groups showed that the decarboxylation step proceeds with 
retention of configuration for both amino acids. 57> 58>59
[2,2,3,3-2H4]Putrescine hydrochloride (85) was fed to S. isatideus 
by Rana and Robins.60 2 H-Labelling patterns were established by 2H 
NMR spectroscopy. The H-2, H-6a, H-6p and H-7a positions of 
retrorsine (86) were labelled equally. The retention of 2H at H-7a 
excludes the involvement of keto or enol intermediates during the 
hydroxylation process atC-7 (Scheme 18).
A similar experiment with [l,l,4 ,4 -2H4]putrescine dihydrochloride 
(87) showed almost exclusive labelling of the right hand ring of 
retrorsine (88), in the H-3cc, H-3p, and H-9 pro-S positions. This can 
be explained via the following route (Scheme 19). The combination 
of the labelled putrescine (87) with unlabelled material would give 
the 2H4-labelled homospermidine (89). Intramolecular 2H isotope 
effects during oxidation of (89) to the aldehyde would favour the 
formation of the left hand ring from the unlabelled half, with the 
labelling mostly in the right hand portion. Also the retention of 
deuterium in the H-9 pro-S position of retrorsine (88) indicates that 
the reduction of the pyrrolizidine aldehyde to the alcohol must
Scheme 18
D
(85) (86)
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proceed with the hydride addition to the re-face of the carbonyl
function (Scheme 19).
Scheme 19
Independently the groups of Spenser6! and Robins62 prepared 
(R)- and (5)-[l-2H] putrescine dihydrochloride. Robins and co­
workers fed this labelled putrescine to 5. isatideus. The sample of 
retrorsine (90) obtained from feeding the (7?>-isomer (91) had equal 
labelling in the H-3f3, H-5a, H-8a and H-9 pro-S positions (Scheme 
20). Feeding of the 5-isomer (92) resulted in the labelling of only the 
H-3a and H-5(3 of retrorsine (93). These results show that the 
oxidation of the primary amines to aldehydes in putrescine and 
homospermidine occur with stereospecific loss of the pro-S 
hydrogens. The reduction of the imine (84) to homospermidine must 
proceed via hydride addition to the C-si-face of the imine. 
Incorporation studies with the same precursor into5. vulgaris by
(87) (89)
y
D
D
3 4
Grue-Sorensen and Spenser gave results which agreed with these 
findings (Scheme 20).
Kunec and R o b in s 6 3  also prepared (R)- and (S)-[2-2H]putrescine 
dihydrochloride (Scheme 21). Starting from L-aspartic acid (94), (S)- 
2-chlorosuccinic acid (95) was formed with retention of 
configuration. The diacid was esterified then selectively reduced to 
the diol (96). Deuteride displacement of the chloride gave the diol 
(97). Chromic acid oxidation of this material resulted in (R)-[2- 
2H]succinic acid (98) for literature comparison, while the diol was 
also converted into (R)-[2-2H]putrescine dihydrochloride (99). The 
corresponding (S)-isomer (100) was prepared from D-aspartic acid 
(Scheme 21).
Scheme 20
(91)
- -  OH
Composite labelling patterns
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These two precursors were fed to S. isatideus. Feeding of the (R)- 
isomer resulted in labelling of the H-2 and H-6a positions of 
retrorsine (101), while the H-6b and H-7a positions of the alkaloid 
(102) were labelled from the (S)Asomer (Scheme 22). This implies 
that hydroxylation at C-7 occurs with retention of configuration, and 
that the unsaturation must be introduced with the retention of the 
pro-R hydrogen at position C-2 of retrorsine.
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Scheme 22
(101)2cr
(99)
(102)2cr
(100)
Kelly and Robins*** also fed (R)- and fSM2-2H]putrescine 
dihydrochloride to S. pleistocephalus. Deuterium was incorporated 
into H-2p and H-6a of rosmarinine (103) after feeding the (R)- 
isomer, while the (S) isomer labelled the H-la, H-60, and H-7a 
positions in rosmarinine (104) (Scheme 23). These results show that 
hydroxylation at C-2 also proceeds with the retention of 
configuration. Furthermore, at the C-l position the pro-S hydrogen is 
retained and the pro-R is lost when the pyrrolizidine ring is formed.
Scheme 23
NH- D '
(103)
NH-
2cr (104)
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Robins also studied the base portion otonecine, produced by 
Emilia flam m ea ,65 With the exception of the necessary loss of 
deuterium  when the keto group is form ed a t C-8, the labelling 
pattern  was exactly analogous to tha t observed for retronecine. 
Introduction of the keto group and cleavage of the bicyclic ring 
does not involve the loss of deuterium  from  the surrounding 
sites.
As a result of the extensive research on the necine bases most 
of the biosynthetic pathways and the stereochem istry of the 
enzymic processes have been established, and thus the labelling 
investigations in to  the biosynthesis o f necines are  nearly  
complete.
38
C hap ter 2.2 B iosynthesis o f Necic Acids
Although the study of the biosynthesis of the necine bases 
has been extensive, less work on the necic acid portions has been 
reported. All the research has involved the use of radiotracers. 
There have been no studies reported using stable isotopes.
Necic acids are mono- or di-carboxylic acids containing 
between five and, most commonly, ten carbon atoms. They 
normally have branched chains and highly oxygenated 
structures. The fact that m any consist of ten carbon atoms led to 
the original suggestion tha t they were terpene derived, despite 
the highly oxygenated nature of the necic acids.
However this theory was dispelled when Hughes and  W arren 
showed that [2-14C]mevalonolactone was no t a  specific precursor 
for the acid portion of retrorsine (7) in Senecio isatideus.25 There 
were also m any attem pts to feed radiolabelled acetates to 
other Senecio species, but no conclusions could be drawn from 
the incomplete labelling patterns obtained.25’26’66
HQ
Me
(7)
3 9
The next area to be investigated was the possibility tha t the 
necic acids are derived from a-am ino acids. Crout e t ad. 26 
dem onstrated that isoleucine (14) and threonine (104) were 
incorporated into seneciphyllic acid (105), produced by Senecio 
douglasii.
Crout also showed that DL-[4-14C]-valine was incorporated to 
the extent of 0.246% into echimidinic acid (107), compared to 
0.019% for [2-14C]-acetate,27 when fed to Cynoglossum officinale. 
The high rate of incorporation for valine indicates that it m ay be 
a  precursor, and  in support of this 85% of the radioactivity was 
found in the acid portion. Degradation studies on the heliosupine 
(108) showed that almost all of this activity was present in the 
acetone and iodoform (Scheme 24). It was concluded, therefore, 
that echimidinic acid (107) is formed from valine (109) with the 
incorporation of an additional C2 unit.
(14) (104)
8
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It was also dem onstrated by Crout tha t the angelic acid 
portion of heliosupine (108) is derived from  isoleucine.28 L-[U- 
i4C]-Isoleucine was fed to C. officinale and was incorporated to 
the extent of 0.205%. This com pared favourably with the 0.019% 
incorporation achieved with [2-l4C]-acetate. As 98% of this 
activity was found in the angeloyl ester portion of heliosupine
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(108), isoleucine was shown to be a specific precursor for angelic 
add.
Tiglic acid (110) is known to be formed from isoleucine in 
Datura meteloidesfi7 McGaw and Wooley68 found that [1- 
14C] tiglic acid was specifically incorporated into the angelic acid 
portion of heliosupine. This suggests that tiglic acid (110) is 
converted into angelic acid (111) via a cis-trans isomerisation 
mechanism.
(110) ( i l l )
The feeding of [1-14C]- and [2-14C]-acetate to Senecio douglasii 
resulted in random isation of the label between the acid and base 
portions,26 ruling out the possibility of there being a direct route 
from acetate to seniciphyllic acid. [2-14C]Mevalonate was 
incorporated to a small extent (0.025%), although more than half 
of the activity was incorporated into the acid portion. If [2-14q  
mevalonate was incorporated directly, half of the activity would 
be located in the C-l and C-8 positions of seneciphyllic acid. 
Degradations showed that these positions contained 0.35% and 
0.17% respectively of the total activity. Although any further 
degradation was impossible due to  the low activity of the acid, 
the results obtained m eant that the possibility of an acetate- 
mevalonate pathway could be dismissed.
The incorporations of L-[U-14C]isoleucine and L-[U- 
14C]threonine were significantly higher into seneciphylline (112) 
than for acetate. Moreover virtually all the activity was located
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in the acid portion. The seneciphyllic acid obtained from L-[U- 
14C]-threonine (113) was degraded as shown (Scheme 25).
JOH
(112)
Scheme 25
31.0
34.2
0.5OH
(a) Ozonolysis
(b) Periodate / permanganate
The results show that the threonine is not incorporated in an 
equal fashion into each half of seneciphyllic acid. When it was 
discovered that [ l - 14C]isoleucine was incorporated with one 
tenth of the efficiency of [U-14C] isoleucine, and with dramatically 
reduced specificity, it became clear that the carboxyl group of 
isoleucine is lost during biosynthesis.
A m ajor pathway in the metabolism of threonine leads to a- 
ketobutyric acid ( 1 1 4 ),69 which is also involved in  isoleucine 
biosynthesis with the other two carbons coming from  pyruvate 
(Scheme 26).
4 3
Scheme 26
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If threonine is incorporated via isoleucine two pathways to 
seneciphyllic acid are possible (Scheme 27).
Scheme 27
,OH
HQNH2 nh2
Studies on the structurally similar senecic acid (115) 
indicated an even distribution of label between both  halves of 
the necic acids.70
HQ
co2h
Also, [2-14C]- and [6 - 14C]-isoleucine were shown to be 
precursors of senecic acid (115). The form er labelled C-l and C- 
1 0  exclusively and  equally, and 58% of the activity from the
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latter isoleucine feed was located a t 0 8  of senecic acid. This is 
consistent with path  (b) of Scheme 27. Path (a) was previously 
preferred due to increased labelling of C-6/C-7 over C-10 of 
seneciphyllic acid after feeding [U-14C] threonine to S’, douglasii.
It is known, however, that a  uniform ly labelled threonine can 
be modified in vivo  to introduce an inequality of labelling at C- 
1 /0 2  and C -3 /0 4 .
Threonine aldolase is known to exist in certain higher 
plants .71 The action of threonine aldolase, acetaldehyde 
dehydrogenase and acetyl CoA synthase is shown in Scheme 28. 
If any degree of reversibility can exist in the system, the 
distribution of the label will depend on the equilibria and the 
existing amounts of glycine and acetyl CoA. The observed 
uneven distribution of labelling could be explained by 
equilibration of the C-l and C-2 portion with a  pool of unlabelled 
glycine greater than the pool of acetyl CoA.
Scheme 28
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(i) threonine aldolase
(ii) acetaldehyde dehydrogenase
(iii) acetyl CoA synthetase
Crout and co-workers70 completed an  extensive study of the 
biosynthesis of senecic acid (115), the acid portion of senecionine
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(26) produced by Senecio magnificus. Various labelled 
isoleucines and threonines were synthesised containing 14C. The 
labelling patterns obtained by degradations dem onstrated that 
senecic acid was form ed by the com bination of two C-5 units 
derived from isoleucine (14), with the loss of the carboxyl 
groups from each isoleucine moiety, in the m anner shown in 
Scheme 29.
Scheme 29
(115)
It was also shown that of the four stereoisomers of isoleucine, 
only L-isoleucine is incorporated in senecic acid biosynthesis. 72
The S-methyl group of L-[Me-14C]methionine is known to be 
preferentially incorporated into the necic acid portion of 
seneciphylline ( 1 1 2 ) , 70 with between 2 2  and  26% of the activity 
located in the C- 8  position of seneciphyllic acid (106), although 
the total incorporation is low. The C-8  atom  of the necic acids is 
derived from C- 6  of isoleucine, which arises from  the methyl 
carbon of pyruvate.
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As there is evidence73 that the S-methyl of m ethionine (116) 
can be converted into the hydroxymethyl group of serine (117), 
which is in tu rn  transform ed into pyruvate (118) in vivo , it 
seems possible that the m ethyl group of m ethionine enters the 
biosynthetic pathway to isoleucine by conversion into the 
hydroxymethyl group of serine (Scheme 30).
Scheme 30 ^
It is also known that the label from  [Me-14C]methionine is 
incorporated specifically into the hydroxymethyl group of serine 
(118) in pea seedlings.70
The mode of coupling between the C-4 and C- 6  carbons was 
then examined. Crout and co-workers74 attem pted to identify 
the five carbon interm ediate form ed from isoleucine in the 
biosynthesis of senecic acid. However feeding experiments with 
2-methylbutanoic acid (119), angelic acid (111) and 2-methyl-3- 
oxobutanoic acid ( 1 2 0 ) showed that these compounds were not 
specific precursors for senecic acid.
* (118)
(116)
SCoA
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The coupling mechanism was also studied, through feeding 
experiments with [6 -3H]- and [4-3H]-isoleucine on S. magnificus 
and S. isatideus. 74
[6 -3H, 6 -14C] Isoleucine was prepared and fed to S. magnificus. 
When the 3ffci4c  ratio of the labelled alkaloid was com pared with 
that of the precursor, it was observed that approximately 5 /6  of 
the tritium  was retained.
The evidence cannot be unambiguously interpreted due to 
possible isotope effects, but it is clear that one hydrogen of C- 6  
in isoleucine is retained during conversion into C-14 of 
senecionine (26) and it is probable tha t two are retained.
When L-[4-3H, U-l4 C]isoleucine was fed to S. isatideus, the 
results showed that half the tritium  was retained in isatinecic 
acid (121). This limits the oxidation level to which C-4 of the 
isoleucine precursor is raised to that of a carbinol or a vinylic 
methine group. It definitely excludes the involvement of a 
carbonyl function in the coupling mechanism, and dismisses the 
interm ediacy of 2-methyl-3-oxobutanoate. The vinyl m ethine 
functionality appeared particularly attractive, as the 
corresponding amino acid, (3-methylene norvaline ( 1 2 2 ) is 
known in nature, as a metabolite of the fungus Lactarius 
helvus ,75
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The feeding of DL-M3H2]methylenenorvaline resulted in 
exclusive incorporation into senecic acid although the low 
activity of the derived alkaloid prevented any degradation 
studies.
The stereochemistry of the coupling mechanism was also 
addressed by Crout and  his co-workers.76’ 77  Incorporation 
studies with (2S’, 45)-[3,4-3H]- and (25,4i?)-[4-3H]-isoleucine 
showed that the H-4 pro-R  is retained and H-4 pro-S  is lost from 
both labelled isoleucines in the formation of the ten carbon necic 
acids in the Senecio species. This result again dem onstrates that 
the introduction of functionality into C-4 of isoleucine is limited 
to a maximum two electron oxidation and excludes any ketonic 
precursors.
2-Aminobutanoic acid (17) was also shown to be specifically 
incorporated into senecic acid, with the ethyl migration step, in 
the conversion into L-isoleucine, taking place with retention of 
stereochemistry at the migrating centre (Scheme 31).
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The high incorporation of 2-aminobutanoic acid into 
retrorsine (7) was also noteworthy (up to 3.6%). The 
incorporation was higher than  for any other precursor, and it 
was also observed that both  stereoisomers were incorporated 
with nearly equal efficincies.76
Necic acid biosynthesis has also been studied in Crotalaria 
species. L-[U-14C] Isoleucine and  L-[U-14C] threonine were both 
incorporated into monocrotalic acid (123), the acid portion of 
monocrotaline (21), produced by C. retusaJ8 By degradation 
studies the partial labelling pattern  was obtained, and it was 
found that the right hand C5 un it was m ost heavily labelled. It 
seems that this C5 unit is derived from  isoleucine (Scheme 32).
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The exact nature of the biosynthesis of the C3 unit comprising C- 
4 , C-5 and C-8 of monocrotalic acid is still uncertain.
.OH
(21)
Scheme 32 HO 7 CH
5 CO2 H iC 0 2H 
(123)
HO2C' 'NH2 
(14)
OH
H2N ^  ^COs 
(104)
The major alkaloid produced by Crotalaria globifera is 
trichodesmine (124). The acid portion, trichodesmic acid (125), is 
structurally similar to monocrotalic acid. Work by Devlin and 
Robins79  with i4 C-labelled amino acids showed that threonine 
(105) and isoleucine (14) are incorporated to a greater extent 
into the right hand C5 unit, with valine (109) and leucine (126) 
mainly labelling the left hand  portion (Scheme 33).
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Dicrotaline (16) contains 3-hydroxy-3-methylglutaric acid 
(HMG) (15), the simplest necic acid known. Possible precursors of 
HMG are acetate and mevalonate but Denholm and Robins80 
showed that neither these, nor dicrotalic acid itself, were 
incorporated to any degree. However L-[U-14C]threonine and L- 
[U-14C] isoleucine were found to be specific precursors of
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dicrotalic acid. Indeed [4,5-3H]isoleucine was found to label the 
methyl group of the diacid specifically. It was shown therefore, 
that isoleucine provides four out of the six carbons of HMG, with 
loss of the C- 6  methyl and carboxyl group in  one of two possible 
ways (Scheme 34). The origin of the o ther two carbons of 
dicrotalic acid is as yet unknown.
In summary, all of the necic acids studied so far have been 
shown to be derived from a-amino acids. It is hoped that 
through the use of NMR spectroscopy complete labelling patterns 
in pyrrolizidine alkaloids can be obtained by carrying out 
feeding experiments with precursors labelled with stable 
isotopes. Using this approach some of the remaining mysteries of
(16)
Scheme 34
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necic acid biosynthesis may be unravelled. Some studies with 
-H- and ^C-labelled forms of isoleucine and 2-aminobutanoic 
acid are discused in the following chapters.
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CHAPTER 3
D evelop m en t o f  a G eneral Route to  Iso leu cin e
3.1 In tro d u c tio n
The m ajority of the work described in this thesis is concerned 
with the synthesis of precursors labelled with stable isotopes for 
the studies of the biosynthesis of the acid portion of 
pyrrolizidine alkaloids. The previous investigations into the 
pathway have been detailed in  Chapter 2.2. The necic acids have 
been shown to be formed from  a-amino acids, in particular 
threonine and isoleucine.26 As all of the previous experiments 
have involved radiotracers the labelling patterns produced have 
been incomplete due to the lack of suitable degradations. The 
aim was to prepare isoleucines labelled a t specific sites with 2H 
and 13C isotopes. The cost of commercially available isoleucines 
labelled with stable isotopes was prohibitively expensive (e.g. 
[6 -2H3]isoleucine costs £7500 g_1). Feeding experiments with 
these precursors and NMR degradation studies on the resulting 
alkaloids could give valuable inform ation on necic acid 
biosynthesis. As a range of labelled isoleucines, labelled in 
various positions, would be required for incorporation studies, a 
route which involves the build up of the isoleucine molecule by a 
stepwise addition of one and two carbon units would be 
advantageous. This would allow greater flexibility in the 
positions of the label and  the same route might be used for all 
the target compounds. It appeared tha t a modification of the
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route published by Whaley e t a l ^ 1 to labelled valine, would 
provide the best procedure (Scheme 35).
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3.2 D evelopm ent o f a  G eneral Route to  Labelled 
Iso le u c in e s
The starting point of the synthesis was the condensation of 
am inoethanethiol (127) and acetonitrile to give 4,5-dihydro-2- 
methylthiazole (128) in m oderate yield. The mass spectrum  of 
the didehydrothiazole showed a molecular ion peak at m /z  1 0 1 .
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*H NMR spectroscopic analysis showed the m ethyl group as a 
triplet, coupled to the methylene adjacent to the nitrogen, with a 
coupling constant of 1.6 Hz. This reaction was equally successful 
starting from either the free base or the hydrochloride salt, or 
when the free base was generated in  situ.
The next step was alkylation of the m ethyl group. Using butyl 
lithium  the thiazole was alkylated, firstly with ethyl iodide then 
with methyl iodide. Isolation and distillation of 2- 
propylthiazoline (129) before the second alkylation was 
preferable, as attem pting both alkylations in a single pot led to a 
mixture of products. Again the mass spectrum of 2- 
propylthiazoline (129) showed a strong molecular ion peak, at 
m /z  129. In the !H NMR spectrum of (129) the long range 
coupling through the C=N bond between the two methylene 
groups was visible with a  coupling constant of 1.4 Hz. The second 
alkylation was perform ed in the same m anner, although it 
resulted in a slightly lower yield. Distillation of the dialkylated 
m aterial gave the pure sec-butylthiazoline (130). The *H NMR 
spectrum  showed the methyl group as a doublet a t 5 1.10 with a 
coupling constant of 6.9 Hz.
Reduction of the 4,5-dihydro-2-sec-butylthiazole (130) to the 
thiazolidine (131) was then required (Scheme 36). The literature 
procedure used an alum inium /m ercury amalgam in moist ether. 
After a  num ber of attem pts at this reaction, including increasing 
the am ount of amalgam and reflux time, only partial reduction 
was observed. This was indicated by the appearance of the H-2 
signal in the *H NMR spectrum  at 5 4.0. This m ethod of reduction
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was deemed not to be satisfactory and a more reliable m ethod 
was sought.
Scheme 36 
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In an attem pt to achieve reduction of (130) a variety of 
reducing agents was tried. Sodium borohydride, sodium 
cyanoborohydride and lithium aluminium hydride were all 
unsuccessful. Hydrogenation at atmospheric pressure only 
returned starting material. As the prospect of reducing the 
thiazoline did not look promising, an alternative procedure was 
sought. Attention turned to an analogous route using oxazoles. 82
The route began with 2,4,4-trimethyl-2-oxazoline (132). This 
was alkylated using the same procedure as before, with 
iodoethane to give 4,4-dimethyl-2-propyl-2-oxazoline (133), and 
then with iodome thane, to give 4,4-dimethyl-2-sec- 
butyloxazoline (134), in good yield (Scheme 37). The two methyl 
groups appeared in the lH NMR spectrum  at 5 0.88 and 1.08 as a 
triplet and a doublet respectively. However the reduction stage 
again proved troublesome. No oxazolidine (135) could be
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obtained by direct reduction. All the m ethods used with the 
thiazoles were also unsuccessful with the oxazolidines. 
Hydrogenation, using palladium on carbon (10%), in ethanol and 
glacial acetic acid only resulted in the recovery of starting 
m aterial at atmospheric pressure. When this reaction was 
repeated in 2 M hydrochloric acid, hydrolysis to 2 - 
methylbutanoic acid (119), rather than reduction occurred. The 
acid proton was observed at 5 10.89 in the iH NMR spectrum. 
Initially it was thought tha t this com pound might be of value in 
feeding experiments, but the literature revealed that 2 - 
methylbutanoic acid (119) was not a precursor to necic acids74 
(Scheme 37).
Scheme 37
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Reduction was achieved, albeit in low yield, using the 
procedure of Nordin (Scheme 3 8).83,84 The oxazoline (134) was 
first m ethylated to give the oxazolinium iodide (136). This 
reaction proceeded in good yield (92%), resulting in a crystalline 
material which could be recrystallised from  isopropanol to give 
pure 3,4,4-trimethyl-2-sec-butyloxazolinium iodide (136). The 
N-methyl signal was observed at 5 3.24 in the *H NMR spectrum.
Reduction of the oxazolinium salt (136) was achieved with 
sodium borohydride, giving the oxazolidine (137) in low yield. 
Sodium cyanoborohydride also accomplished the reduction, but 
with no improvement in yield. Purification of the oxazolidine 
was by column chromatography on basic alumina.
The hydrolysis of the oxazolidine (137) was also low yielding, 
giving 2-methylbutanal (138) in 22% yield at best (Scheme 38). 
The aldehyde proton occurred as a doublet in the *H NMR 
spectrum, with coupling constant of 2 Hz, at 5 9.53. The ER 
spectrum indicated the presence of the aldehyde carbonyl group 
at 1725 cm-1.
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This procedure (Scheme 38) was also repeated for the 
thiazoline route (Scheme 39). A good yield was achieved for the 
formation of the thiazolinium iodide (139). The reduction stage, 
however, was again low yielding. The best yield obtained was 
less than for the oxazolidine (33%). The hydrolysis of the 
thiazoline (140) to the aldehyde (138) was not achieved.
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2-M ethylbutanal (138) was a useful relay point, as this 
material is commercially available, and the rem ainder of the 
route had actually been accomplished before the problems with 
reduction and hydrolysis steps were encountered. A modified 
version of the Strecker synthesis was used (Scheme 40). The 
aldehyde (138) was converted into the crystalline bisulfite 
addition product (141) in good yield. There was a broad peak at 
1170 cm_l in the IR spectrum  corresponding to the bisulfite 
functionality.
The cyanohydrin (142) was prepared from the bisulfite 
addition product (141) by treatm ent with an aqueous solution of 
sodium cyanide. A good yield (85%) was achieved, yielding the 
product as an oil. There was a weak band at 2250 c n r l [n  the IR 
spectrum corresponding to the nitrile group of the cyanohydrin. 
The carbon of the nitrile function was observed at 5 119 in the 
]3c NMR spectrum.
6 2
A solution of the cyanohydrin (142) in concentrated ammonia 
solution was then stirred at room tem perature. Subsequent 
extraction of the organic extracts of this reaction with 1 0 % 
hydrochloride acid gave the aminonitrile hydrochloride (143). A 
peak in the mass spectrum  at m /z  1 1 2  was observed 
corresponding to M+ minus HC1. The product gave a white solid 
when recrystallised from water. The final stage involved the 
hydrolysis of the nitrile group. Treatm ent of the aminonitrile 
hydrochloride (143) with concentrated hydrochloric acid, for 24 
hours at room tem perature and then seven hours at reflux 
tem perature gave the required DL-isoleucine hydrochloride 
(144) and the allo-racemate (Scheme 40). The 13C NMR spectrum 
showed the carboxylic acid carbon at 5 175, and the C=0 stretch 
in the IR spectrum  showed an absorption at 1700 cm-1.
Scheme 40
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This final product was analysed by 13C NMR spectroscopy, and 
shown to be an approximately 1: 1 ratio of DL-isoleucine and DL- 
allo-isoleucine. It is known that only L-isoleucine is incorporated 
in the necic acid biosynthesis. Separation of the m ixture was not 
necessary as the other isomers have no adverse effects, bu t it 
m eant that only one quarter of the mixture of hydrochlorides 
prepared was useful for incorporation studies. In combination 
with the  fact tha t the overall yield was low, the result was that 
this route was not economically viable as a general route for the 
synthesis of a  range of isoleucines labelled with stable isotopes.
3.3 Synthesis o f [6 -2 H3 ]-Iso leucine a n d  Alio- 
iso leu c in e  H y d ro ch lo rid e
The route described above was used to prepare [6 -2H3]- 
isoleucine and [6 -2H3]-allo-isoleucine hydrochloride (145). 2,4,4- 
Trimethyloxazoline was alkylated with ethyl iodide, then the 
deuterium  label was introduced via alkylation with PH3]- 
iodomethane. The rem ainder of the route was as previously 
described. All yields obtained were com parable to those 
achieved with unlabelled material. The deuterium  labelled 
products were examined by 2H NMR spectroscopy and mass 
spectroscopy. A broad singlet a t 5 0.70 in the deuterium  NMR 
spectrum of the amino acid hydrochloride (145) showed the 
presence of the 2H labelled methyl group.
The crucial stages of this synthesis were the reduction of the 
oxazoline and hydrolysis of the product. Although these steps 
were eventually accomplished, the poor yields of these reactions 
drastically reduced the overall yield. The procedure was only
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used once, to prepare a few milligrams of [6-2H3]-isoleucine 
hydrochloride (145), and the alio isomer, bu t this material was 
not used in feeding experiments as an  insufficient am ount could 
be prepared.
CHAPTER 4
Synthesis o f a Specifically Labelled Isoleucine
4.1 In tro d u c tio n
As it was not possible to develop a general synthetic route to a 
range of labelled isoleucines (Chapter 3), it was necessary to devise a 
synthesis for each individual precursor labelled in the required 
positions.
Dicrotaline (16) was first isolated by Marais from Crotalaria dura 
and Crotalaria globiferap5 and contains 3-hydroxy-3-methylglutaric 
acid (HMG) (15) which is the simplest diacid found in pyrrolizidine 
alkaloids. 3-Hydroxy-3-methylglutaric acid is a well known 
metabolite in biosynthesis, and is usually formed from acetate on the 
pathway to mevalonate and terpenes. However tracer studies by 
Denholm and Robins80 demonstrated that acetate and mevalonate 
were not incorporated into the acid portion of dicrotaline. It was 
found however, that isoleucine and threonine are precursors for 
HMG. Feeding experiments with Crotalaria lachnosema indicated that 
isoleucine contributes four out of six carbons of the 3-hydroxy-3- 
methylglutaric acid portion. The carboxyl group and the C-6 methyl 
group of isoleucine are both lost. The origin of the remaining two 
carbons is still unknown. The isoleucine precursor appears to label 
four of the six carbons of HMG, as shown in Scheme 34.
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The dicrotaline extracted from C. lachnosema consists of a mixture 
of dicrotaline and 13-O-acetyldicrotaline86 (18). For ease of analysis 
the mixture was converted wholly into the acetylated alkaloid. A full 
NMR spectroscopic analysis showed that, unlike in HMG itself, the 
two methylene groups in the acid portion of 13-Oacetyldicrotaline 
have distinct chemical shifts and can be distinguished87 (Chapter 6).
In an attempt to identify which side of the necic acid is 
incorporated into isoleucine a route to [3-2H]isoleucine (146) was
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req u ired . As [2-2H ]-2 -bu tano l (147) is com m ercia lly  
available the route used by Hill e t a/, to p repare radiolabelled 
isoleucine was developed88 (Scheme 41). They used lithium  
alum inium  tritiid e  to in troduce 3H and [2-14C]malonate to 
incorporate 14c.
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4.2 Development of a Synthetic Route to [3- 
2H]Isoleucine
In accordance with the synthesis used by Hill e t al.y 2-butanol
(148) was converted into 2-butylmethanesulfonate (149) by reaction 
with mesyl chloride and triethylamine (Scheme 42). The reaction 
proceded in good yield (90%). The methyl signal of the sulfonate
(149) appeared at 6 3.0 in the *H NMR spectrum and the sulfonate 
was detected by bands at 1350 and 1170 cm-1 in the IR spectrum. 
The mesylate (149) could be distilled to give the product as a 
colourless liquid.
The mesylate was treated with dimethyl malonate to yield 
dimethyl2-sec-butylmalonate (150). Sodium hydride was used as 
the base and the mixture was heated at reflux temperature for 
around 48 hours. Distillation of the product gave the diester (150) in 
good yield (86%). The *H NMR spectrum of (150) showed a doublet at 
6 3.7 corresponding to the H-2 proton a to the ester functions. Basic 
hydrolysis of the diester (150) with aqueous sodium hydroxide gave 
the sec-butylmalonic acid (151), which crystallised in a desiccator 
overnight. The signal for the H-2 proton was observed as a doublet 
in the *H NMR spectrum at 6 3.36 and the acid protons appeared as a 
broad singlet at 6 11.04. The mass spectrum showed a peak for the 
molecular ion at m /z  160.
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The preferred reaction of Hill et al. was a direct Schmidt reaction, 
using hydrazoic acid solution on the diacid (151) to give isoleucine 
(14). This reaction is analogous to the Curtius rearrangement except 
it is the protonated azide that undergoes the rearrangement89 
(Scheme 43).
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However this procedure proved unsuccessful. Attempted Schmidt 
reactions on the diacid (151) with hydrazoic acid in benzene or 
toluene gave a mixture of substituted aromatic species, and no 
isoleucine could be isolated. Using a solution of hydrazoic acid in 
chloroform, with 100% sulfuric acid, DL-isoleucine and DL-allo- 
isoleucine could be prepared but results were erratic and yields 
were very low when the reaction was successful (Scheme 42).
A more reliable procedure was required and an alternative 
method involving bromination, decarboxylation and displacement 
was used. The diester (150) was brominated according to known 
methods.90 A good yield (94%) of the bromodiester (152) was
achieved. The quaternary carbon signal in the 13C NMR spectrum
was observed at 5 70.1. Unfortunately basic hydrolysis did not give 
the diacid.
However, reversal of these two steps gave the desired
bromomalonic acid (153). The quaternary carbon at 5 73.5 was seen 
in the 13C NMR spectrum. Again, crystallisation of the diacid was by 
leaving overnight in a desiccator.
When the malonic acid (153) was subjected to heat, 
decarboxylation occurred.94 There were two doublets at 5 4.2 in the 
iH NMR spectrum due to the a-H in the diastereomers. The ratio of 
diastereomers was approximately 1:1. Unfortunately the yield of this 
reaction was less than the previous stages (42%). The a-bromo-0- 
methylvaleric acid (154) was added to concentrated aqueous
ammonia solution and stirred overnight. The isoleucine and allo- 
isoleucine were isolated as the hydrochloride salts (144) (Scheme 
44).
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The overall yield of this synthesis was 10.3% which was 
satisfactory for the preparation of [3-2H] isoleucine hydrochloride 
(146).
4.3 Synthesis of [3-2H]Isoleucine and Allo-isoleucine 
H ydrochloride
A mixture of [3-2H] isoleucine and [3-2H]alloisoleucine 
hydrochloride was prepared, using the procedure described above, 
starting from [2-2H]butan-2-ol. Again, examination of the 2H 
products obtained was by 2H NMR spectroscopy. The yields for the 
deuterium labelled route compared favourably for the yields
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obtained for the unlabelled material. A signal at 5 1.63 in the 2H 
NMR spectrum corresponds to the deuterium label at the 3-H 
position of the isoleucine hydrochloride.
4 .4  Feeding of [3-2H] Isoleucine hydroch lo ride
The labelled precursor mixture was dissolved in sterile water and 
fed to medium sized Crotalaria lachnosema plants by the wick 
method. The feeding was continued over 14 days and the plants 
were harvested in the usual manner after a further four days. The 
alkaloid mixture extracted was converted wholly into 13-0 
acetyldicrotaline (18), using acetyl chloride in a refluxing solution of 
acetic anhydride.
4.5 Results and  Discussion
As a result of previous biosynthetic studies and NMR 
spectroscopic analysis, it was expected known that feeding of the [3- 
2H] isoleucine would label one of the four positions at either 12-pro-R 
or 12-pro-S proton, at 5 3.26 and 2.41 respectively, or the 14-pro-R 
or 14-pro-S proton at 5 2.93 and 2.78. Unfortunately the 2H NMR 
spectrum showed no signals at these positions nor any of the other 
chemical shifts known for the alkaloid although the lH NMR 
spectrum showed that 13-0-acetyldicrotaline was present. There 
were however strong signals at 5 0.90 and 1.12 in the 2H NMR 
spectrum. The cause of these peaks is unknown.
So, although the C. lachnosema plants appeared healthy at the 
time of feeding and harvesting, there appeared to be no 
incorporation of the isoleucine into the necic acid portion of the 13- 
0-acetyldicrotaline sample obtained.
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CHAPTER 5
Synthesis o f  Labelled 2-A m inobutanoic Acid
5.1 In tro d u c tio n
A known biosynthetic precursor of necic acids is 2-aminobutanoic 
acid.16 Crout and co-workers77 fed radioactively labelled forms of 2- 
aminobutanoic acid to Senecio isatideus, and found that the 
incorporations were high (up to 3.6%), and that the label was 
exclusively in the acid portion. It was also observed that both L- and 
D-2-aminobutanoic acid were incorporated into the acid portion. It 
was proposed that isoleucine (14) was formed from 2-aminobutanoic 
acid after conversion by the appropriate enzyme (amino acid 
aminotransferases or oxidases) into 2-oxobutanoic acid (155) 
(Scheme 45).
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Notably, Crout and co-workers also showed that in the generation 
of both of the five carbon units of the C10 necic acid the C-3 pro-S 
hydrogen of the 2-aminobutanoic acid is lost and the C-3 pro-R 
hydrogen is retained. Corresponding experiments with isoleucine 
found that the C-4 pro-S hydrogen is lost and the C-4 pro-R 
hydrogen is retained. This demonstrated that the ethyl migration 
step takes place with retention of configuration in (156), agreeing 
with previous hypotheses based on orbital symmetry arguments.92
There have also been reports of the occurrence of 2- 
aminobutanoic acid in a number of higher plants.93 Most 
importantly, the reported finding of the R-isomer in legume seeds94 
and of a 2-oxobutanoate aminotransferase in pea seedlings95 seem to 
suggest that the conversion of 2-aminobutanoic acid (17) into 2- 
oxobutanoate (155) may be a normal metabolic process.
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These results suggested that 2-aminobutanoic acid would be an 
interesting and useful probe for investigations of the necic acid 
biosynthetic pathway using precursors labelled with stable isotopes.
5.2 P reparation  of 2-Am inobutanoic Acid
A short and efficient synthesis of 2-aminobutanoic acid was 
known.96 Starting from diethyl acetamidomalonate (157), and using 
sodium ethoxide as a base, the first step is an alkylation with ethyl 
iodide (Scheme 47). This gave diethyl 2-ethylacetamidomalonate 
(158) in a yield of 75%. The ethyl group appeared in the 13c NMR 
spectrum with signals at 5 7.7 and 13.9, and the lH NMR spectrum 
showed a triplet and a quartet at 5 0.77 and 2.36 respectively. The 
coupling constants for both these signals was 7.6 Hz. An alternative 
alkylation was also achieved, starting from ethyl 
acetamidocyanoacetate (159), but with no improvement in the yield. 
The alkylated products (158) and (160) from these reactions could 
be recrystallised to white crystalline material. Hydrolysis of these 
compounds in concentrated hydrochloric acid gave 2-aminobutanoic 
acid as the hydrochloride salt (161). Recrystallisation of the salt from 
95% ethanol gave the product in good yield. The C-4 and C-3 
positions of the amino acids corresponded to the signals at 5 9.3 and
24.0 respectively in the l3C NMR spectrum. The XH NMR spectrum 
showed triplets at 5 0.82 and 3.79 corresponding to the methyl 
group and the proton at H-2 respectively. The methylene protons 
were observed as a multiplet at 5 1.78. Microanalysis of the salt also 
gave satisfactory data (Scheme 46).
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5.3 Synthesis of [3,4-2H5]-2-Am inobutanoic Acid and 
[l3C2]-2-Aminobutanoic Acid H ydrochloride
The synthesis was then carried out with labelled material. The 2H 
and 13C labels were introduced at the alkylation stage. Using 2Hs- 
iodoethane afforded [3,4-2Hs]-2-aminobutanoic acid (162) and 
alkylation with [13C2]-iodoethane gave [3,4-13C2]-2-aminobutanoic 
acid (163). The production of these labelled amino acids was verified 
by NMR spectroscopy. The 2H NMR spectrum of (162) showed two 
broad singlets at 5 1.20 and 2.16 of relative intensities 3: 2. The 
deuterium content was greater than S 5  %, estimated from the NMR 
spectra.
The 13c NMR spectrum of (163) contained two large doublets at 5
9.3 and 24.2, with a coupling constant of 34 Hz, along with very
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small natural abundance signals. Again around 99.9 % labelled 
material was obtained. The yields obtained with the labelled 
material were equivalent to those achieved with the unlabelled 
material.
18
HQ
C02H
- -  OH
* — D3 C— cd 2
(8)
5.4 Feeding Experiments w ith 2-A m inobutanoic acid
The 2H-labelled (162) and 13C-doubly labelled 2-aminobutanoic 
acids (163) were fed to two plants and two transformed root 
cultures which produce pyrrolizidine alkaloids. The labelled amino 
acid salts were dissolved in distilled water and fed by the wick 
method to Senecio pleistocephalus and Crotalaria lachnosema 
plants. The 13C2-labelled material was fed to small plants to limit the 
amount of endogenous unlabelled material. As the 2H signals should 
be easier to observe over natural abundance by NMR spectroscopy, 
the deuterium labelled 2-aminobutanoic acid was fed to older, 
larger plants.
For feeding to Senecio vulgaris and Emilia flammea root cultures 
the precursors were dissolved in water, sterilised and divided among 
ten flasks containing seven day old roots. The roots were filtered off
78
and extracted after a further 14 days. The alkaloids were purified by 
preparative TLC.
5.5 Results and  Discussion
The acid portion of rosmarinine (8) produced by Senecio 
pleistocephalus is senecic acid (115). After feeding [3,4-l3C2]-2- 
aminobutanoic acid the alkaloid was extracted and examined by i3C 
NMR spectroscopy. Compared with the 13C NMR spectrum of 
unlabelled romarinine run under the same conditions the 13C NMR 
spectrum of the labelled rosmarinine showed four doublets of 
approximately equal intensity at 8 11.7, 15.1, 37.8 and 134.6. The 
corresponding coupling constants for these doublets were 36.4, 42.0,
36.3 and 42.0 Hz respectively. The labelling corresponds to the C-13 
and C-19 positions, plus the C-20 and C-21 positions of rosmarinine. 
There was equal labelling in both halves of the necic acid. The 
incorporation of the 2-aminobutanoic acid was 0.43%. The 13C NMR 
spectrum of the labelled romarinine is shown in figure 1.
The 2H NMR spectrum of the rosmarinine sample obtained, after 
feeding [3,4-2Hs]-2-aminobutanoic acid to S. pleistocephalus was also 
examined. Three signals were observed at 5 0.88, 1.75 and 5.79. The 
relative intensities of these signals were approximately 3: 4: 1, 
respectively. The signal at 5 0.88 corresponds to the methyl group at 
C-19, and the C-20 vinylic proton has the chemical shift
(115)
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corresponding to the 2H signal at 5 5.79. However the !H NMR signals 
of the C-21 methyl group and the C-13 proton have very similar 
chemical shifts. Judging by the relative intensities of these signals it 
would appear that these peaks are superimposed. The incorporation
!
' of the amino acid, calculated from integration of the 2H signals, was
0.7 %. The relative integrals of the signals suggest no loss of 2H from 
i  the two methyl groups or H-13 and H-20. This rules out carbonyl
groups at C-13 and C-20 as intermediates in the biosynthetic 
pathway. This observation is consistent with the earlier work of 
Crout and c o - w o r k e r s .  77 Figure 2 shows the 2H NMR spectrum of the 
rosmarinine sample obtained after the feeding of [3,4-2Hs]-2- 
aminobutanoic acid hydrochloride.
Although the 2H NMR spectrum contained two overlapping 
signals, when coupled with the 13C feeding results it can be stated 
that for rosmarinine (8 ), produced by S. pleistocephalus, the C-3 and 
C-4 positions of 2-aminobutanoic acid are exclusively and equally 
incorporated into the two halves of the senecic acid (115), labelling 
solely the C-13 and C-19 alkaloid positions of the right hand portion 
and the C-20 and C-21 positions of the left hand C5 unit.
HQ
0
HO CH<
c o 2h
(115)- -  OH
(8)
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Senecic acid is also the acid portion of senecionine (26), from 
Senecio vulgaris. Although the incorporation of the precursor (163) 
was not as good as for rosmarinine (8), in the 13c NMR of senecionine 
sample doublets could be observed around the signals at 5 11.1, 15.1
38.4 and 134.3. The respective coupling constants were 36, 42, 36, 
and 42 Hz. Again, the amounts of label in each half of senecic acid 
were approximately equal. Figure 3 shows the 13c NMR spectrum of 
the senecionine obtained.
After feeding [3,4-2Hs]-2-aminobutanoic acid to S. vulgaris the 2H 
NMR spectrum showed three peaks, appearing at 5 0.91, 1.81, and 
5.78. These signals correspond to labels at H-19, H-13 plus H-21 and 
H-20. The ratios of the relative intensities (approximately 3: 4: 1) 
indicate that, as for rosmarinine, the H-13 signal and the signal for 
the methyl group at H-21 positions are co-incident. The specific 
incoporation was 0.5%. These experiments show that in senecionine, 
produced by S. vulgaris, 2-aminobutanoic acid is a biosynthetic 
precursor. The C-3 and C-4 positions of the amino acid are converted 
into C-20 and C-21 of the left hand unit and the C-13 and C-19 
positions of the right hand unit. There is equal labelling into each 
half of the acid portion (Figure 4).
HQ .CH;
(26)
The transformed root culture Emilia flammea is known to produce 
the alkaloids emiline (81) and senecionine (26). The emiline appears
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to be produced iate in the biosynthetic cycle. The period for 
maximum recovery of emiline has been shown to be between 21 and 
29 days.97 The aim of the feeding experiment to £  flammea was to 
maximise the labelling of emiline, as information on senecionine was 
obtained from S. vulgaris.
Two feeding experiments with [3,4-2Hs]-2-aminobutanoic acid 
were carried out with £  flammea. In the first feed the cultures were 
harvested after 19 days. The 2H NMR spectrum of the alkaloid 
mixture showed signals a t 5 0.90, 1.80, 5.75 and 6.54. However, these 
signals can be assigned to labelling of senecionine (26) and its 
geometrical isomer integerrimine (164), in an approximate 2: 1 
ratio.98 There was very little 2H signal corresponding to the vinylic 
methylene group at 5 5.10 present in emiline99. The 2H NMR 
spectrum is shown in figure 5. When the alkaloid mixture was 
studied by TLC [eluted in CHCl3:MeOH:NH3 (85:14:1)] and the 
alkaloids were visualised by Dragendorff s reagent, there was no 
evidence that any emiline was present.
(81)
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(26) (164)
This feeding experiment was repeated with £  flammea and 
harvesting was carried out after 26 days. Again, examination by TLC 
and lH NMR spectroscopy showed that no emiline was present. When 
feeding experiments were carried out with £  flammea with Re­
labelled 2-aminobutanoic acid the alkaloid extract was examined by 
NMR spectroscopy. Unfortunately only a small amount of alkaloid 
mixture was isolated and no signals could be observed in the 13C 
NMR spectrum.
Feeding experiments with both 2H- and RC-labelled 2- 
aminobutanoic acid were carried out with young plants of Crotalaria 
lachnosema. On this occasion the plants suffered from severe 
withering and very little alkaloid could be extracted. No 
incorporation of label was observed.
When the experiments with C. lachnosema were repeated the 
daily amount of precursor fed was reduced and the feeding was 
continued over a longer period. At harvesting time the plants 
appeared healthy and the plants were extracted according to the 
normal procedure.
The alkaloid mixtures were acetylated and samples of 13 -0  
acetyldicrotaline (18) were obtained. Considering the feed with RC2- 
labelled aminobutanoic acid first, the alkaloid extract yielded only 3
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mg. Although the 13C NMR signals for the 13-O-acetyldicrotaline 
present were present, no enrichment was observed and no doublet 
could be seen around the natural abundance signals of any of the 
carbons. The low amount of alkaloid obtained prevented any further 
studies. It may be that alkaloid is not produced at this stage of plant 
growth.
o
(18)
The 2H NMR spectrum of the alkaloid sample obtained by feeding 
the deuterium labelled aminobutanoic acid to Crotalaria lachnosema, 
however, showed no incorporation of 2H into any position of 13-O- 
acetyldicrotaline.
Tracer experiments by  Denholm and Robins80 have shown that 
the 3-hydroxy-3-methylglutaric acid (15) portion of dicrotaline is 
formed from isoleucine with loss of both the 6-methyl and carboxyl 
groups (Scheme 34).
84
4
Me
Scheme 34
c o 2h
C 02H 1 C 0 2H
4
i c o 2h c o 2h
As a result of this work the label from [3,4-2H5]-2-aminobutanoic 
acid was expected to be solely located in the C-13 methyl group at 5h 
1.72. From these experiments, therefore, the results obtained have 
been mixed. On the plus side, the first stable isotope studies of the 
necic acid biosynthesis were achieved. Good 2H and 13C NMR spectra 
were obtained from alkaloids isolated from feeding experiments 
with S. pleistocephalus and S. vulgaris. These showed conclusively 
that in the Senecio species senecic acid (115) is formed from two 
units of 2-aminobutanoic acid. The C-3 and C-9 positions of senecic 
acid are generated from the C-3 of 2-aminobutanoic acid, and the C- 
8 and C-10 diacid positions were originally the C-4 of the amino acid. 
It has also been shown that there is equal incorporation into both 
halves of the necic acid.
Examination of the 2H labelling pattern of the senecionine 
produced from £  flammea supported these results. Unfortunately 
there was not enough emiline present in the alkaloid mixture to 
obtain any information on the biosynthesis of the acid portion (165) 
of emiline.
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Unfortunately the feeding experiments with C. lachnosema did not 
give any data on the biosynthesis of the 3-hydroxy-3-methylglutaric 
acid portion. Despite careful feeding conditions no incorporation of 2- 
aminobutanoic acid was observed. These African plants are slow 
growing and do not thrive in our northern climate. It is clear that 
alkaloid levels are low in these plants and very little new alkaloid 
was produced during the course of the experiments.
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CHAPTER 6
Assignment of NMR Spectra and Conform ational Analysis 
of 13-O -A cetyldicrotaline
6.1 In tro d u c tio n
Dicrotaline (16) is known to be the major pyrrolizidine alkaloid 
produced by Crotalaria lachnosema.86 As 13-O-acetyldicrotaline (18) is 
also present, the most convenient method of analysis is to convert all 
the alkaloidal material isolated to the acetylated product.
(16) R = H 
(18) R = OAc 
(166) R = Me
Work by Denholm and Robins80 identified isoleucine as a precursor. 
For stable isotope studies on 13-O-acetyldicrotaline a full assignment 
of the iH and 13C NMR spectra was required. Particular problems to be 
resolved were: (1) the distinction of the two halves of the symmetrical 
3-acetoxy-3-methylglutarate portion (including the pro-R and pro-S 
assignments of the protons); (2) the stereochemical assignments of the 
methylene protons of the necine; and (3) the relative conformation of
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the carbonyl ester groups of 13-O-acetyldicrotaline for use in possible 
structure activity relationships.
6.2 Results and  Discussion
The mixture of dicrotaline (16) and 13-Oacetyldicrotaline (18) was 
extracted from C. lachnosema and converted into 13-0 
acetyldicrotaline. 100 The and 13C NMR spectra of this sample were 
studied at 4.7T with the help of Dr. D. S. Rycroft. The signals are 
named from A to Q, in increasing order of shielding for the purpose of 
this discussion. The chemical shifts and coupling constants are listed in 
table 1 .
The proton on the double bond (Ha) was identified at 5 5.90, 
coupling to three methylene protons, vicinally to F and G at C-3, and 
allylically to E at C-9. These two methylene positions were identified 
by the greater deshielding of B and E relating them to 9 -H2. The fact 
that no coupling was observed between A and B implies that B lies in 
the plane of the double bond. Similarly, homoallylic coupling of 3 -H2 
with E but not with B supports this. The 3 -H2 protons also couple with 
the methylene proton at C-8  (D). The signal D also couples with 
allylically to proton A and the methylene proton C, which is C-7. Signal 
C correlated with the combined signal for the resonances of N and O, 
assigned to 6 -H2. The methylene protons at C-5, signals H and L, also 
correlated to 6 -H2.
Furthest upfield was the doublet, Q, at 5 1.72, corresponding to the 
methyl group attached to C-13. The signal P was due to the acetate 
methyl group. The two halves of the glutarate portion were 
distinguished by a 2D 5c / 5h  long range correlation experiment. 101
The furthest downfield carbonyl signal was at 5 168.7. As this 
correlated with B and E (9 -H2) and with I and M, assigned to 12-H2 on
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the acid portion, this signal was assigned to C -ll. The most deshielded 
carbonyl signal correlated with the methyl protons (P) of the acetate. 
The remaining carbonyl signal (5 169.5) must therefore be C-15, as it 
correlated with J and K which were assigned to 14-H2. However no 
correlation was observed with H-7.
To determine the stereochemical questions, NOE difference 
experiments were used. The results obtained are shown in Table 2.
The protons at C-8 and C-7 must be on the same side of the 
molecule because of the NOEs between A and B. As the proton B has 
already been deduced to be planar to the double bond, the 
conformation around the C-9 bond must be as shown in Figure 6.
Other NOE findings agreed with this conclusion. Arising from the 
three spin effect102 there was a negative NOE at E after irradiation of 
A, and a negative NOE at D after irradiation of B. Signal B was 
therefore assigned as the H-9 pro-S proton, and E as the pro-R proton 
of H-9. Substantial NOEs were observed between G and L but not 
between F and H. Signals G and L were therefore assigned as the 13- 
protons of C-3 and C-5 respectively, on irradiating at F, a negative NOE 
was observed at L and vice versa. This was consistent with the 
assignment.
A more complex analysis was necessary to determine the 
stereochemistry of the acid portion. Long range proton-proton 
couplings around C-12, C-13 and C-14 indicated that one conformation 
was preferred.
The C-13 methyl group (Q) couples only to K, whereas irradiation of 
Q, caused positive NOEs at the methylene protons J, I and M, but a 
small negative NOE at K. This implies that QJs gauche to J, I and M, but 
antiperiplanar to K, as shown in figure 6. Signal J was assigned to the 
H-14-pro-R and K to the H-14-pro-S proton. A coupling constant of 1.2 
Hz between I and J was observed due to the near W-coupling path
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Table 1. NMR parameters* of 13-0-acetyldicrotaiine (2) (CDC13 solution)
Site "c 4m Label Multiplicity 2J  (Hz) V  (Hz)0 *J  (Hz)0
1 132.5
2 131.4 5.90 A quin. 2.0 (3a), 2.1 (30) 1.6 (8), 1.5 (7)
3a 61.9 3.88 F dtd 15.8 2.0 (2) 2.9 (8)
30 3.40 G ddt 15.8 2.1 (2) 5.6 (8)
5a 53.7 3.28 H dm 8.9 I  = 8.8 (6a. 60)
50 2.55 L dm 8.9 E = 18.0 (6a. 60)
6a, 60 34.0 2.07 N, 0 m
7 75.1 5.16 C dt 4.4 (8), I  = 5.0 (6a. 60)
8 77.0 4.30 D br m
9-pro-R 60.2 4.09 E ddq 12.2 1.5 (2), 1.3 (8)
S-pro-S 5.31 B d 12.2
11 168.7
12 -pro-R 41.3 3.26 I dd 15.6 1.2 (14 -pro-R)
12 -pro-S 2.41 M d 15.6
13 79.5
14-pro-R 43.7 2.93 J dd 13.4 1.2 (12 -pro-R)
14-pro-S 2.78 K dq 13.4 0.8 (13-M e)
15 169.5
13-Me 26.1 1.72 Q d 0.8 (14-jDro-S)
13-0-Ac 22.3 2.00 P . s
13-0-C 0 170.2
*J  (Hz)°
2.9 (9-pro-R ) 
1.7 (9-pro-R )
2.9 (3a), 1.7 (30)
’Absolute values of coupling constants are show n. Sc is relative to CDCI3 at & 77.0 and 6 H is relative to CHCI3 at 6  7.25. 
“The site number of the coupling partner is given in parentheses.
Table 2. NOEs observed* in 13-O-acetyldicrotaline (2)
Proton irradiated.0 label and percentage saturation
2 3a 30 5a 50 6a. 0 7 8 9 -pro-R 9-pro-S  12 -pro-R 12-pro-S 14-pro-i7 13-Me
Site ot A F G H L N. 0 C 0 E 8 1 M J Q
NOE 63 32 19 34 34 17° 50 48 23 40 37 41 30 66
2 5 4 - 2 7
3a 3 23 - 1
30 1 25 6
5a 31 2
50 - 1 5 21 - 2
6a, 0 d 2 2
7 0.5 13 1 0 2 0.4
8 2 1 0 3 - 1
3-pro-R -1 2 34
9 -pro-S 3 33
12-pro-R 40 2
12-pro-S 2 28 5
14-pro-R 6
14-pro-S -0 .4
13-Me 0.4 1 1
JThe NOEs reported are the result of scaling up the observed NOEs in inverse proportion to the degree of saturation in order to obtain 
values equivalent to  the result of complete saturation.
“No NOEs were observed when H -14-pro-S  or the acetate protons were irradiated.
“Average saturation of the combined signal. In reporting the NOEs in this column it has been assum ed that the tw o protons were equally 
saturated.
“Scaled-up percentage enhancem ents of the combined signal.
Ac
C-13
C-14
G^V'12
C-15
0-10
0-16
C-9
C-7
C-lC-6
C-lN.O
C-2
C-3N-4
I ^ S ' a c e t y S t l n ^  Pr° DOSed preferred conform at.on o f
between J and H-12-pro-R. Therefore I was attributed to the latter 
proton and M to H-12-pro-S.
The X-ray crystal structure results on studies with 13,13-dimethyl -
1,2-didehydrocrotaline picrate, the picrate salt of (166),103 combined 
with the assignments deduced above suggested that the preferred 
conformation of 13-O-acetyldicrotaline must be similar to that shown 
in figure 6.
The ester carbonyl functions are antiparallel with the C-l5 
carbonyl group on the a-face, and the C -ll carbonyl group on the 13- 
face of the molecule. In conformations where the C -ll carbonyl group 
is directed below the plane of the macrocycle Hg is displaced out of 
the plane of the double bond. Also, in conformations when the C-l5 
carbonyl group is directed above the plane of the macrocycle it was 
impossible to achieve the correct relationship around the C-l2, C-l4 
and C-l 5 region.
Further evidence in support of the conformation shown in figure 6 
came from analysing the effect of changing the C -ll carbonyl group 
on the chemical shifts of the 9-H2 protons. In 13,13-dimethyl-1,2- 
didehydrocrotaline picrate (166) these protons were observed at 5 
4.08 and 5.32, very similar to the shifts in 13-O-acetyldicrotaline. 
Dicrotaline (16) shows the chemical shift of the 9-H2 protons as 5 4.18 
and 5.41, possibly due to hydrogen bonding of the hydroxyl group. 
Naturally occurring pyrrolizidine alkaloids derived from retronecine, 
and containing an 11-membered ring, mainly have the ester groups 
syn-parallel and directed below the plane of the macrocycle.2 These 
conformations normally have the substituent on the a-face at C-13 
approximately antiperiplanar to the (3-substituent of both C-13 and C- 
14. This was not observed in the analysis of 13-O-acetyldicrotaline.
A few significant NOEs were observed between necine and acid 
portion protons. Irradiation of the H-12-pro-S proton caused a NOE at
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C (H-7), and vice versa. Irradiation of the methyl protons Q, also 
caused a NOE at C. The conformation shown in figure 6 does not 
explain these NOEs, but they may be accounted for by a contribution 
from a conformational equilibrium from other conformations where 
the C-13 end of the macrocycle is folded down, The NOEs also required 
that the methyl protons Q, and the proton M are on the underface of 
the molecule as shown in figure 6. This confirmed that the 
configuration of C-13 is S, agreeing with previous degradation 
experiments.100 If the configuration were R, there could be no possible 
conformation which would give the NOEs observed. Thanks are due to 
Dr. D. S. Rycroft and Miss I. Freer for their help in carrying out this 
work. This work has been published.
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CHAPTER 7
Form ation o f Synthanecines
7.1 In tro d u c tio n
Synthetic analogues of pyrrolizidine alkaloids are required for 
metabolic and toxicological studies. The first synthesis of the most 
common necine retronecine (4) was reported in 1962,105 but the 
route was lengthy and the overall yield was low (<1%). This led to 
the preparation of a range of monocyclic analogues of pyrrolizidine 
bases, called synthanecines. 106,107 pQr example, synthanecine A is
2,3-bis( hydroxy methyl)-l-methyl-3-pyrroline (19) and
synthanecine B (20) is the corresponding saturated derivative. The 
structural similarity of synthanecines A and B to retronecine (4) and 
platynecine (167) respectively, is shown.
OH
OH
(19)
OH
OH
(4)
OH
OH
(167)
OH
(20)
92
Synthanecines A and B were required for feeding experiments 
and a route for the synthesis of novel synthanecines for the 
investigation of possible anti-tumour activity was developed.
7.2 Formation of Synthanecines A and B for Feeding 
Experim ents
The synthesis of synthanecines A and B has been well 
documented. 106,108,109 Mattocks originally prepared a range of 
analogues for toxicology studies, while possible anti-tumour activity 
was investigated by Barbour 108 and by Baxter. 109 It was intended 
that synthanecines A and B would be prepared, using known 
procedures, for feeding experiments with S. vulgaris. The root 
cultures would then be extracted and the extracts analysed for the 
appearance of any new alkaloid analogues.
A modified version of the procedure initially developed by 
Mattocks 106 was used to form the synthanecines (Scheme 47). 
Additional spectroscopic data have also been reported. Methylamine 
was added to diethyl maleate (168) to give diethyl 2- 
methylaminosuccinate (169) in good yield (81%). The iV-methyl 
signal appeared at 5 2.42 in the iH NMR spectrum. The single C-H 
proton was observed as a doublet of doublets at 8 3.55.
The diethyl 2-methylaminosuccinate (169) was then alkylated by 
treatment with ethyl bromoacetate to yield the triester (170). There 
were three triplets at 8 1.25, 1.27, and 1.30 in the iH NMR spectrum. 
All these signals had coupling constants of 7.1 Hz. The spectrum also 
showed a singlet at 8 3.43 ppm corresponding to the methylene 
position adjacent to the nitrogen.
Dieckmann cyclisation of the triester (170) with 95% sodium 
hydride resulted in the formation of diethyl l-methyl-4-
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oxopyrrolidine-2,3-dicarboxylate (171). The structure of the cyclised 
product was verified by an absorption at 1770 cm '1 in the IR 
spectrum, due to the cyclic ketone. In the iH NMR spectrum the ring 
methylene group appeared as AB systems with geminal coupling 
constants of 17 Hz.
Reduction of the ketone with sodium borohydride gave the 
hydroxypyrrolidine (172). There was a broad signal at 3450 cm '1 in 
the IR spectrum for the O-H function. There were three peaks in the 
13c NMR spectrum corresponding to the different diastereomers.
This hydroxypyrrolidine (172) was dehydrated in pyridine using 
p-toluenesulfonyl chloride to the pyrroline diester (173). Any 
pyrrolic material (non-basic) formed in this reaction was easily 
removed by an acid-base wash of the products. The vinylic proton 
appeared at 5 6.88 in the !H NMR spectrum. The C=C stretching 
frequency was observed at 1645 cm '1 in the IR spectrum, and the 
unsaturated C-H stretch showed at 3020 cm-1.
Synthanecine A and synthanecine B could both be formed from 
this intermediate. The correct choice of reducing agent for reduction 
of the pyrroline diester (173) was crucial. Using the fact that di- 
isobutylaluminium hydride does not reduce C=C bonds, reduction 
with lithium aluminium hydride gave synthanecine B (20), while 
reduction with DIBAL gave mainly synthanecine A (19) (Scheme 47). 
The IH NMR spectrum of synthanecine A showed the hydroxyl 
protons as a broad signal at 5 4.65. The vinylic proton appeared as a 
broad peak at 5 5.62. Synthanecine B was formed as a mixture of 
diastereomers. The O-H groups appeared as a broad singlet at 5 4.90 
in the iH NMR spectrum.
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Synthanecines A and B were thick gums and purification was a 
problem. The normal acid-base wash procedure was impossible due 
to the water solubility of the amino diols. Mattocks' method using 
buffer solution proved unsuccessful. 106 The formation of crystalline 
hydrochloride and oxalate salts of the synthanecines was not 
achieved either. Column chromatography on basic alumina was 
found to be the best purification method. Synthanecines A and B 
were then fed to the transformed root culture S. vulgaris.
7.3 Results of Feeding Experiments w ith Synthanecines 
A and B
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Synthanecines A and B were fed to Senecio vulgaris root cultures. 
The cultures were extracted after 21 days and the extracts were 
studied by TLC and mass spectroscopy. There was no evidence of 
any material other than senecionine present in either mixture.
7.4 P reparation of Synthanecines for Testing of Anti­
tum our Activity
The variety of the biological action of pyrrolizidine alkaloids has 
encouraged a detailed investigation of their properties. As 
synthanecine A biscarbamate (174) has shown anti-mitotic activity ,2 
the preparation of synthetic analogues of pyrrolizidine alkaloids for 
similar studies is an attractive proposition. In an attempt to develop 
a short, efficient synthesis to synthanecines the 1,3-dipolar 
cycloaddition reaction published by Roussi and co-workers110 was 
studied. This suggested the possibility of using trimethylamine N- 
oxide (175), to generate the azomethine ylid (176), which should 
undergo 1,3-dipolar cycloaddition with a range of alkenes, to furnish 
a range of pyrrolidines. Roussi e t ah, observed cycloadditions with 
allyl alcohol and a series of unfunctionalised alkenes (Scheme 48).
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The pyrrolizidine ring structure was also constructed using this 
procedure, with the R groups being phenyl, alkyl or acetal 
functions111 (Scheme 49).
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This 1,3-dipolar cycloaddition reaction is important, because 
previously azomethine ylids were known only to be formed from 
precursors bearing electron withdrawing or conjugating substituents, 
formed, for example, by thermal ring opening of aziridine or by the 
deprotonation of iminium salts.il2 jh e  ylid produced from 
trimethylamine N-oxide is an extremely reactive species and can be 
quenched by simple alkenes (hex-l-ene, cyclopentene or 
cyclohexene). The stabilised ylids only react with activated 
dipolarophiles (ethylene dicarboxylic esters, phenylmaleimide, etc.).
Roussi and co-workersU° reported the cycloaddition of ylid (176) 
with allyl alcohol (177). A repeat of this reaction was attempted, 
together with further cycloadditions with propargyl alcohol (178), 
dimethyl acetylenedicarboxlate (179), diethyl fumarate (180), 
diethyl malonate (181) and cis-4,7-dihydro-l,5-dioxepin (182) 
(Scheme 50).
However, many attempts at repeating the cycloaddition with allyl 
alcohol were unsuccessful in forming 3-hydroxymethyl-l- 
methylpyrrolidine (183). Visualisation of the TLC plate with 
Dragendorff s reagent, specific for tertiary amines, showed that no 
product had been formed. The reaction was attempted at 
temperatures between 0 and -78°C, and reaction times up to 24 
hours. A similar reaction with propargyl alcohol (178) also did not 
appear to yield any of the expected pyrroline (184).
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avoid the possible ring opening to the water soluble amino diol 
species, TLC monitoring of the reaction mixture did not reveal a spot 
with the Dragendorff reagent. It was obvious after the failure of the 
dioxepin to undergo cycloaddition, that this method was not practical 
as a route to synthanecines and that some other procedure was 
required. The reactions which were attempted are summarised in 
table 3.
Table 3
Dipolarophile Reaction Temp. Reaction Time
Allyl alcohol -7 8  °C 4 h and 6  h
0 °C 4 h and 20 h
Propargyl alcohol -78 °C 4 h
Diethyl maleate -7 8 °C 4 h and 8  h
0 °C 4 h and 20 h
Diethyl fumarate -78 °C 4 h and 6  h
0 °C 3 h and 6  h
Dimethyl acetylene- -78 °C 6 h
dicarboxylate
0°C 6  h
ris-4,7-Dihydro- -78 °C 4 h
1,5-dioxopin
0°C 4 h
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7.5 A lternative Procedure for 1,3-Dipolar
Cycloaddition Reactions
When the procedure used by Roussi and co-workers110 could not 
be repeated to give the synthanecines an alternative method was 
needed. A recent publication by Begue et a7. 113 noted the formation 
of fluorinated pyrrolidine rings via 1,3-dipolar cycloaddition. The 
method had been developed from a procedure where non- 
fluorinated, disubstituted alkenes activated by a carbonyl group 
reacted with an azomethine ylid to provide pyrrolidines in good 
yields114 (Scheme 52).
This procedure used N-benzyl-N-(trimethylsilylmethyl)- 
aminomethyl methyl ether (188) to generate the azomethine ylid 
(189). The required aminomethyl methyl ether was prepared in 
good yield from N-(trimethylsilylmethyl)benzylamine (190), with 
formalin in methanol (Scheme 53).
Scheme 52
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The iH NMR spectrum of the product showed a multiplet 
corresponding to the benzyl group, and five singlets at 5 0.0, 2.1, 3.2, 
3.7 and 4.0. The trimethylsilyl group appeared at 5 0.0 and the 
methylene group adjacent to the silicon at 5 2.1. The signal at 5 3.2 is 
indicative of the methyl ether group, and the two other singlets are 
due to the benzyl methylene and the methylene group between the 
nitrogen and the oxygen.
Decomposition of the amino methyl ether (188), catalysed by 
trimethylsilyl trifluoromethanesulfonate and caesium fluoride, 
generates the unstabilised azomethine ylid (189), which can react 
with electron deficient alkenes. The cycloaddition proceeds 
stereospecifically in good yield (Scheme 54).
Scheme 54
Me3SiCH2
CH2Ph 
N.
MeSiOTf
CH2OCH3 CsF
r  r
X
©  @
H2C^ ch2
kN
CH2Ph
©
H2C ^  @
CH2Ph
(189)
This cycloaddition method was successful with dimethyl 
acetylenedicarboxylate (179) and diethyl fumarate (180) (Scheme
1 0 2
55). Reaction with the alkyne (179) gave the pyrroline (191). The 
presence of the cyclised product was demonstrated by the 
appearance of a molecular ion peak in the mass spectrum. XH NMR 
spectroscopy showed three singlets in a ratio of 3:1:2, corresponding 
to the methyl ester groups and the two different methylene 
functions. All these signals had similar chemical shifts, around 5 3.8. 
The 13C NMR spectrum showed both olefinic carbons appearing co- 
incidently at 5 137.1.
1,3-Dipolar cycloaddition of the ylid (189) with diethyl fumarate 
(180) also gave the desired product in good yield (84%). The 
pyrrolidine (192) also showed a molecular ion peak in the mass 
spectrum at m /z  305. The product appeared to be formed 
stereospecifically, with only one racemate observed in the 13 C NMR 
spectrum. iH NMR spectroscopic analysis of the pyrrolidine showed a 
triplet at 5 1.18 and a quartet at 5 4.09, with coupling constants of
7.2 Hz, corresponding to the ethyl ester groups. The benzylic 
methylene position appeared as a singlet at 5 3.54, with the 
pyrrolidine ring protons identified as multiplets at 5 2.78 and 5 3,39. 
Purification of the cyclised products was by preparative TLC, eluted 
with ethyl acetate.
The pyrrolidine (192) was taken one step further and reduced 
with di-isobutyl aluminiumhydride, to yield the diol (193). The 
product is a crystalline material, with a melting point of 82°C. The 
13c NMR spectrum of (193) showed the C-3 and C-4 positions at 5 
44.6. The three different methylene groups corresponded to signals 
at 5 57.7, 60.2, and 65.7. A peak at m /z  221 in the mass spectrum 
also indicated the formation of the synthanecine (193) (Scheme 55).
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Unfortunately lack of time prevented further elaboration of this 
route.
7.6 Conclusions
Repeated attempts at using the procedure of Roussi and co­
workers UO to furnish a range of synthanecines were unsuccessful. 
The 1,3-dipolar cycloaddition reaction with electron deficient 
alkenes appeared to undergo side reactions readily, but there is no 
explanation as to why the cycloaddition with allyl alcohol, as 
reported by Roussi, could not be repeated. However from N- 
(trimethylsilyl methyl)benzylamine it was possible to achieve 1,3- 
dipolar cycloaddition, after conversion into the methyl ether, using 
the procedure described by Begue et. al. 113 It should be possible to
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prepare a variety of synthanecines using this short and efficient 
synthesis.
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CHAPTER 8
E xperim ental
8.1 G eneral
Melting points were measured on a Kofler hot-stage apparatus 
and are uncorrected. Mass spectra were obtained with A.E.I. MS 12 
or 902 spectrometers. Nuclear magnetic resonance (NMR) spectra 
were recorded with a Perkin Elmer R32 spectrophotometer operating 
at 90 MHz (5 h ), a Varian EM 390 spectrophotometer operating at 90 
MHz (5 h ) or a Bruker WP200-SY spectrophotometer operating at 200 
MHz (5 h ), 50.3 MHz (5 c ) ,  or 30.72 MHz (5 d ). The multiplicities of the 
13C NMR resonances were determined using DEPT spectra with pulse 
angles of 0 = 90° and 6 = 135°. Spectra were recorded for solutions in 
deuteriochloroform unless otherwise stated, with either CHCI3 or 
tetramethylsilane (TMS) as an internal standard. Infrared spectra 
(IR) were obtained on either a Perkin Elmer 983 spectrophotometer 
or a Philips PU 9800 FTIR spectrophotometer. Elemental analyses 
were performed using a Carlo-Erba 1106 elemental analyser.
Thin layer chromatography (TLC) was carried out on Merck 
Kieselgel G (silica) plates of 0.25 mm thickness. Plates were 
visualised with Dragendorffs reagent unless otherwise stated. The 
TLC plates were eluted with the solvent system CH3Cl:MeOH:NH3 
(85:14:1) unless otherwise stated.
Tetrahydrofuran (THF) was dried by distillation from sodium- 
benzophenone under nitrogen prior to use. Other solvents and 
reagents were purified by standard techniques. Acetic anhydride 
was distilled from calcium hydride and stored over 4A sieves.
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Triethylamine was distilled from, and stored over, potassium 
hydroxide.
Organic solvents were dried with anhydrous sodium sulfate and 
solvents were evaporated under reduced pressure below 50°C
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8.2 Experimental for C hapter 3
Synthesis of 4 ,5-D ihydro-2-m ethylth iazole (128)
Triethylamine (4.45 ml, 3.172 g, 31.3 mmol) was added to 
aminoethanethiol (3.569 g, 31.3 mmol) in methanol (40 ml) and 
stirred for 1 h. Acetonitrile (1.280 g, 31.3 mmol) was then added and 
the mixture was heated at reflux temperature for 24 h. The 
methanol was distilled off and the residue was partitioned between 
ether (30 ml) and water (30 ml). The ether layer was separated and 
the aqueous layer was extracted with ether (8  x 30 ml). The 
combined ether layers were dried over anhydrous potassium 
carbonate and filtered. The ether was then removed by distillation 
yieding the title compound as a pale yellow oil (3.168 g, 41%); umax 
2980 (C-H), 1680 (C=N), 1480, 1180 (N=C-S) 940, and 750 cm-l; 5H 
(200 MHz) 2.07 (3H, t, J 1.6 Hz, CH3), 3.17 (2H, t, J 8.4 Hz, 5-H2), 4.06 
(2H, tq, J 8.4, 1.6 Hz, 4-H2); 5C 19.6 (CH3), 34.3 (C-5), 64.4 (C-4), 166.4 
(C-2); m /z  101 (M+ 58.6%), 73, 60 (100%), 59, 55; (Found: M+ 
101.0302. C4H7NS requires M, 101.0299).
Synthesis of 4 ,5-D ihydro-2-propylth iazole (129)
A three-neck flask was equipped with a magnetic stirrer and two 
dropping funnels under a nitrogen atmosphere. The flask was 
charged with 2-methyl-2-thiazoline (9.386 g, 0.093 mol) and 
anhydrous THF (100 ml). The reaction mixture was cooled to -78 °C 
and butyl lithium (85 ml, 1.0 M in hexanes, 0.085 mol) was added 
slowly. The reaction mixture was stirred at -78 °C for an additional 1 
h before ethyl iodide (13.3 ml, 0.085 mol) was added dropwise. The
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reaction mixture was again stirred at -78 °C for 1 h before the 
temperature was raised to approximately 10 °C and the stirring was 
continued for 2 h. After this time, the reaction mixture was poured 
onto ice (200 g). The aqueous layer was adjusted to pH 2 with 1M 
HC1 and the organic layer was separated. The aqueous layer was 
extracted with hexane (50 ml) and was then adjusted to pH 10 with 
20% NaOH. The thiazoline was extracted from the aqueous phase 
with hexane (4 x 40 ml) and the combined organic extracts were 
dried over anhydrous potassium carbonate. Filtration and 
evaporation of the solvent gave the crude 4,5-dihydro-2- 
propylthiazole. Distillation of the crude product gave the title 
compound as a colourless liquid (8.552 g, 78%); Umax 2960 (C-H), 
1630 (C=N), 1460, and 1150 (N=C-S) and 983 cn rl; 5H (200 MHz) 
0.88 (3H, t, J 7.3 Hz, CH3 ), 1.53-1.64 (2H, m, CH2CH3 ), 2.40 (2H, tt, J
7.3, 1.4 Hz, CH2C=N), 3.18 (2H, t, J 8.4 Hz, 5-H2), 4.12 (2H, tt, J 8.4 Hz,
1.4 Hz, 4 -H2); 5C 13.5 (CH3 ), 20.7 (CH2CH3), 33.5 (CH2C=N), 36.0 (C-5), 
64.3 (C-4), 171.3 (C-2); m /z  129 (M+ 12.5 %), 114, 101, 70, 60 
(100%); (Found: M+129.0613. C6HnNS requires M, 129.0612).
Synthesis of 4 ,5-D ihydro-2-sec-buty lth iazo le (130)
The procedure was carried out as previously described for 4,5- 
dihydro-2-propylthiazole using 2-propylthiazoline (4.1017 g, 31.8 
mmol); THF (80 ml); butyl lithium (1.0 M in hexanes, 30 ml, 30 
mmol); and methyl iodide (1.88 ml, 4.25 g, 30 mmol).
Distillation of the crude mixture yielded the title compound as a 
colourless liquid (2.7456 g, 64%); Umax 2980-2860 (C-H), 1630 (C=N), 
1460, 1200 (N=C-S), 990, 925 cn rl; 5H (200 MHz) 0.84 (3H, t, J 5.8 
Hz, CH3CH2), 1.10 (3H, d, J 6.9 Hz, CH3CH), 1.33-1.62 (2H, m, CH2CH3), 
2.53 (1H, m, CH), 3.14 (2H, t, J 8.3 Hz, 5 -H2), 4.11 (2H, dt, J 8.3, 0.84
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Hz, 4-H); 5c 11.4 (CH3CH2), 18.5 (CH3CH), 28.3 (CH2CH3 ), 32.8 (CH2S),
40.6 (CH), 64.1 (CH2N). 176.4 (C); m /z  143 (M+ 3.9%), 128, 115 
(100%), 114, 8 6 , 83, 57; (Found: M+ 143.0769 : C7H13NS requires M, 
143.0769).
A ttem pted Synthesis of T e trah y d ro -sec -b u ty lth iazo le  
(131)
Aluminium foil (35 g) was treated with 5% KOH (200 ml) for 10 
min after which time the basic solution was removed and the metal 
was washed with water (200 ml). The aluminium was then treated 
with 0.5% mercuric chloride solution (200 ml). After 5 min the 
solution was removed and a second treatment with aqueous 
mercuric chloride was carried out. The foil was washed successively 
with water (100 ml), 95% ethanol (2 x 50 ml) and diethyl ether (2 x 
50 ml). The flask containing the foil was fitted for reflux with an 
efficient condenser and a solution of 4,5-dihydro-2-sec-butylthiazole 
(0.575 g, 4.01 mmol) in moist ether (30 ml) was added. The reaction 
mixture was heated at reflux temperature for 5 d and, after cooling, 
the ether solution was filtered. The aluminium amalgam was washed 
with ether (2 x 20 ml), and the ether solutions were combined. After 
removal of the ether, the residual oily product was dried over 
anhydrous potassium carbonate. The drying agent was separated 
and washed with small amounts of ether. Removal of the ether 
yielded mainly starting material and only a very small amount of 
product.
A ttem pted Synthesis of T e trah y d ro -2 -sec-b u ty lth iazo le  
(131)
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The thiazoline (0.1451 g, 1 mmol) was dissolved in m ethanol (5 
ml) and  cooled to 0 °C. Sodium borohydride (0.152 g, 4 mmol) 
was dissolved in 50% m ethanol (5 ml) and added dropwise. The 
m ixture was then stirred  for 1 h. Cold 1M HC1 was added until 
the solution reached pH 2. The solvent was then removed under 
reduced pressure and the residue was taken up in 1M NaOH (10 
ml). The alkaline solution was then extracted with chloroform (3 
x 1 0  ml) and the com bined organic extracts were washed with 
brine (3 x 10 ml), dried, filtered and concentrated in vacuo. No 
thiazolidine was obtained.
Attempted Synthesis of Tetrahydro-2-sec-
butylthiazole (131)
The thiazoline (0.101 g, 1 mmol) was dissolved in 50% ethanol 
(10 ml) and  3M HC1 was added to adjust the pH to 5. The flask 
was then  cooled to 0°C and a slightly alkaline solution of sodium 
cyanoborohydride (0.189 g, 3 mmol in 5ml H2O containing 2 
drops of 30% NaOH) was added dropwise. The tem perature was 
kept a t 0 °C and the pH was m aintained between 4 and 6  by the 
addition  of 3M HC1. After hydride addition was com plete the 
m ixture was stirred  for 30 min, then  d ilu ted  w ith w ater (30 
ml).The pH was then  adjusted to 9 - 10 and the solution was 
extracted w ith e ther (4 x 30 ml). The com bined extracts were 
dried and concentrated in vacuo. No thiazolidine was observed in 
the *H NMR spectrum.
Attempted Synthesis of Tetrahydro-2-sec-
butylthiazole (131)
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A solution of the thiazoline (0.100, 1.0 mmol) in dry THF (10 ml) 
was added dropwise over 30 min to a solution of lithium aluminium 
hydride (114 mg, 3 mmol) in THF (10 ml). The mixture was heated 
at reflux for 48 h. Again, there was no thiazolidine observed.
A ttem pted Synthesis of T etrahyd ro -2 -sec-b u ty lth iazo le  
(131)
To a stirred solution of sodium borohydride (0.7182 g, 18.9 mmol) 
and 2-methylthiazole (0.6757 g, 4.73 mmol) in 1,4 dioxan (20 ml) 
was added acetic acid (10 ml) in dioxan (20 ml) dropwise at 0 °C. The 
resulting mixture was stirred at reflux temperature for 2 h. The 
reaction mixture was concentrated in vacuo and excess reagent was 
decomposed with water and 1M hydrochloric acid (20 ml) and ethyl 
acetate (20 ml) was added. The aqueous layer was basified with 
potassium carbonate. The organic layer was separated and the 
aqueous layer was extracted with ethyl acetate (3 x 20 ml). The 
combined organic layers were dried, filtered and concentrated under 
reduced pressure. Only starting material was recovered.
A ttem pted Synthesis of T etrah y d ro -2 -sec-b u ty lth iazo le  
(131)
2 -sec-Butylthiazoline (0.2467 g, 6.49 mmol) was added to a 
suspension of palladium on carbon (10 % w/w) in absolute ethanol 
and hydrogenated at 1 atm for 48 h. The suspension was then 
filtered through Celite and the ethanol was removed under reduced 
pressure. This reaction yielded only starting material.
Synthesis of 4 ,4-D im ethyl-2-propyl-2-oxazoline (133)
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The procedure was carried out as previously described for 4,5- 
dihydro-2-propylthiazole using 2,4,4-trimethyl-2-sec-butyl- 
oxazoline (4.60 ml, 4.083 g, 0.036 mol); butyl lithium (1.6M in 
hexanes, 45 ml, 0.035 mol); THF (50 ml); and ethyl iodide (5.4610 g, 
0.035 mol).
Distillation of the crude residue gave the title compound as a 
colourless liquid (4.769 g, 94%); b.p. 145 °C ; Umax (thin film) 2980- 
2880 (C-H), 1670 (C=N), 1190 (C-O), 990, 975, and 930 cnrl; 6h (200 
MHz) 0.88 (3H, t, J 7.3 Hz, CH3CH2), 1-18 (6H, s, (Me}2C), 1.55 (2H, m, 
012013), 2.15 (2H, t, J 7.2 Hz, N=CCH2), 3.82 (2H, s, 5-H2); 5C 13.5 
(CH3CH?), 19.3 (CH2CH3), 28.3 (Me?C), 29.8 (N=CCH2), 66.7 (C-4), 78.7 
(C-5), 165.8 (C=N); m /z  141 (M+ 1.5%), 126, 113 (100%), 98, 70, 55; 
(Found: M+ 141.1152: C8H15NO requires M, 141.1154).
Synthesis of 4 ,4-D im ethyl-2-sec-butyl-2-oxazoline (134)
The procedure was carried out as previously described for 4,5- 
dihydro-2-sec-butylthiazole using 4,4-dimethyl-2-propyl-2- 
oxazoline (3.229 g, 22.9 mmol); THF (60 ml); butyl lithium (1.6M in 
hexanes, 13.75 ml, 22.0 mmol); and methyl iodide (1.37 ml, 3.142 g, 
22 mmol). Distillation of the crude reaction product gave the title 
compound as a colourless liquid. (2.1881 g, 64%); Umax (thin film)
2970 - 2940 (C-H), 1665 (C=N), 1160 (C-O), 1005, 975, and 925 cn rl; 
5 h  (200 MHz) 0.88 (3H, t, J 7.0 Hz, CH3CH2), 1.08 (3H, d, J 7.0 Hz, 
CH3CH), 1.23 (6H, s, Me?C), 1.62 (2H, m, CH2CH3 ), 2.32 (1H, m, CH), 
3.85 (5-H?); 5c 14.1 (CH3CH2), 17.4 (CH3CH), 26.9 (CH2CH3), 28.4 
(Me2C), 35.0 (CH), 66.6 (CMe2), 78.8 (C-5), 169.2 (C=N); m /z  155 (M+ 
0.5%), 140, 127, 102, 58 (100%), 57; (Found: 155.1325: C9Hi7ND 
requires M, 155.1340).
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Formation of [9 -2 H3] -4 ,4 -D im eth y l-2 - s e c -b u ty l-2 - 
oxazoline
The procedure was carried out as for unlabelled material but 
using d3-iodomethane in 62% yield, 5p 1.07 (CD3CH)
A ttem pted Synthesis of 4,4-D im ethyl-2-sec- 
butyloxazolidine (135)
4,4-Dimethyl-2-sec-butyl-2-oxazoline (1.552, 10 mmol) was
added to a suspension of palladium on carbon (1 0 % w/w) in ethanol 
under a nitrogen atmosphere at 1 atm for 48 h. The suspension was 
then filtered through Celite and the ethanol was distilled off. The 
clear liquid obtained was shown to be starting material.
The reaction was repeated in glacial acetic acid and again, only 
starting material was found.
When the above procedure was carried out in 2M HC1 the reaction 
gave 2 -methylbutanoic acid as a colourless liquid. umax (thin film)
3020 (br O-H), 2965-2940 (C-H), 1710 (C=0), 1230 (C-O), 940 cnrl; 
5 h  (200 MHz) 0.91 (3H, t, J 7.4 Hz, 013^ 2), 1.14 (3H, d, J 7.0 Hz, 
OfeCH), 1.43-1.72 (2H, m, CH2), 2.34 (1H, m, CH), 10.89 (1H, br s, 
© 2H); 5c 11.5 (CH3CH2), 16.3 (CH3CH), 26.5 (CH2), 40.9 (CH), 163.5 
(002H); m /z  102 (M+ 0.4%), 87, 74 (100%), 57; (Found: M+ 102.0697: 
C5H10Q2 requires M, 102.0681).
Synthesis o f 3 ,4 ,4 -T rim ethy l-2 -sec-bu ty loxazo lin ium  
iodide (136)
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4,4-Dimethyl-2-sec-butyloxazoline (4.1919 g, 0.027 mol) was 
dissolved in acetonitrile (50 ml) and heated to reflux temperature. 
Iodomethane was added in portions (5 x 2 ml) during the period of 
reflux, around 8  h. After this time the solvent was removed in vacuo, 
and the crude oxazolinium iodide was recrystallised from 
isopropanol to give the oxazolinium salt as a white, crystals (7.377 g, 
92%); Umax (KBr disc) 2980-2880 (C-H), 1385 (CMe2), 1700 (C=N+), 
and 1080 cnr*; 5H (200 MHz) (CD3CN ref CHD?CN @ 1.93) 0.94 (3H, t, 
J 7.4 Hz, CH3CH2), 1.35 (3H, d, J 6.9 Hz, CH3CH), 1.49 (6 H, s, Mg2Q,
1.68 (2H, m, CH2CH3), 3.00 (1H, m, CH), 3.24 (3H, s, NMe), 4.68 (2H, s, 
5-H2); 5C 11.5 (CH3CH2), 16.5 (CH3CH), 23.2 (Me2C), 26.6 (CH2CH3),
28.2 (N-Me), 40.9 (CH), 53.1 (CMe2), 6 8 .6  (C-5), 176.3 (C=N); m /z  170 
(M+ 45.1%), 154, 126, 8 6 , 72, 57, 56, 41 (100%).
Form ation of [9-2 H3]-3 ,4 ,4 -T rim e th y l-2 -sec -
butyloxazolin ium  Iodide
The procedure was carried out as described for unlabelled 
material using [9 -2H3]-4 ,4 -dimethyl-2 -sec-butyl-2 -oxazoline in 94% 
yield, 5D 1.40 (CD3CH).
Synthesis of 3 ,4 ,4 -T rim ethy l-2 -sec-bu ty loxazo lid ine 
(137)
The oxazolinium iodide (1.518 g, 5.11 mmol) was dissolved in diy 
methanol (10 ml) and charged into a flame dried 3-necked flask 
under a nitrogen atmosphere. Sodium borohydride (0.772, 20.4 
mmol) was added, in portions, at 0 °C and the mixture was stirred 
for a further 2  h after the completion of the addition of borohydride. 
Purification by column chromatography on basic alumina (eluted
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with CHCI3), yielded the title compound as a colourless oil (41%); 
Umax (thin film) 3460 (br w), 2960-2880 (C-H), 1380, 1360 (CMe2), 
1230 (C-O), and 1115 cn rl; 5H 0.83-1.10 (6 H, m, CH3CH2, CH3CH), 
0.10 (6 H, s, Me?C), 1.33-1.57 (2H, m, CH2CH3), 1.60-1.82 (1 H, m, 
CHCH3), 2.12 (3H, s, NMe), 3.55 (2H, s, 5-H2), 3.98 (1H, m, 2-H); 5C 
11.5, 12.2 (CH3CH;?), 16.6, 16.8 (CH3CH), 23.7 (Me2C), 26.3, 26.4 
(CH2CH3), 29.9, 30.3 (NMe), 37.4, 37.9 (CHCH3), 59.3, 59,6 (CMe2),
78.3, 78.7 (5-H?), 98.2, 99.6 (2-H); m /z  170, 154, 126, 100, 8 6 , 72, 
57, 55,41 (100%).
Formation of [9 -2 H3] - 3 ,4 ,4 -T rim e th y l-2 -sec-
bu ty loxazo line
The procedure was carried as previously described for unlabelled 
material using [9 -2H3]-3 ,4 ,4 -trimethyl-2 -sec-butyloxazolinium 
iodide in 34% yield, 5d 1-10 (CD3CH).
Synthesis of 4 ,5 -D ihydro -N -m ethy l-2 -sec-bu ty l- 
th iazo lid ine (140)
The procedure was carried out as previously described for 3,4,4- 
trimethyl-2-sec-butyloxazolidine in 21% yield, 5h (200 MHz) 0.90 
(3H, t, J 7.8 Hz, CH3CH2), 1.01 (3H, d, J 6 .6  Hz, CH3CH), 1.18 (2H, m, 
QF2CH3), 1.41-1.72 (1 H, m, CHCH3), 2.26, 2,27 (3H, s, NMe), 2.88 (2 H, 
m, 5-H2), 3.09 (2H, m, 4-H2), 3.93, 3.98 (1H, d J 4.3 Hz, 2-H); 5c 11.0,
11.1 (CH3CH?), 16.2, 16.8 (CH3CH), 27.0, 27.2 (QfeCHs), 29.5, 29.6 (C- 
5), 39.7, 40.0 (CHCH3 ), 58.5, 58.7 (C-4), 83.6, 84.2 (C-2); m /z  159 (M+ 
0.3%), 144, 112, 102 (100%), 98, 84, 71 ,57: (Found: M+ 159.1068: 
C8H17NS requires M, 159.1081).
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Synthesis of 2-M ethylbutanal (138)
The tetrahydro-oxazole (0.180 g, 1.05 mmol) was added to a 
solution of 1M oxalic acid (5 ml) and heated at reflux temperature 
for 2 h. The reaction mixture was then distilled and fractions boiling 
below 100 °C were collected. The reaction mixture was extracted 
with diethyl ether (3 x 5 ml), and the extracts were washed with 5% 
NaHC0 3  solution (5 ml) and dried. Filtration and solvent evaporation 
gave the desired aldehyde in low yield (0,020 g, 22%); l?max (thin
film) 2980-2860 (C-H), 2800, 2700 (0=C-H), 1725 (C=0), 1460, 970 
cm-l; 5 h  (200 MHz) 0.85 (3H, t ,  J 7.5 Hz, 4 -H3 ), 1.00 (3H, d, J 7.0 Hz, 
5 -H3), 1.27-1.69 (2H, m, CH2), 2.19 (1H, dq, J 7.0, 1.9 Hz, 2-H), 9.53 
(1H, d, J 1.9 Hz, 1-H); 5C 11.1 (C-4, 12.6 (C-5), 23.3 (C-3), 47.6 (C-2), 
205.2 (C-l); m /z  86 (M+ 14.0%), 74, 58, 57, 41 (100%), 29; (Found: 
M+86.0728: C5H10O requires M, 86.0732).
Formation of [5-2H 3]-2-M ethy lbu tanal
The procedure was carried out as described above using [9-2H3]-
3,4,4-trimethyl-2-sec-butyloxazoline in 20% yield, 5d 0.98.
Synthesis of 2-M ethylbutanal Bisulfite A ddition Product 
(141)
A solution of 2-methylbutanal (5.110 g, 0.06 mol) in acetonitrile 
(20 ml), was added to a stirred solution of sodium bisulfite (6.120 g, 
0.06 mol) in water (10 ml). The bisulfite addition separated as a 
colourless solid, and the mixture was stirred overnight. The addition 
product was collected, washed with acetonitrile (10 ml) and dried to
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give 2-methylbutanal bisulfite addition product. (8.164 g, 81%); m.p. 
>230°C; Umax (KBr disc) 3550-3400 (br, O-H), 2960-2880 (C-H), 1170 
(br, -SO2-), and 640 cn rl; 5H (200 MHz) (D2O ref. HOD @ 4.63) 0.76, 
0.77 (3H, t, J  7.4 Hz, 4-H3), 0.84, 0.88 (3H, d, J 6.9 Hz, 5-H3), 1.11-
I.36 (2H, m, 3-H2), 1.40-1.88 (1H, m, 2-H), 4.10 (1H, d, J, 1-H); 5C
II.2 , 11.7 (C-4), 13.4, 16.3 (C-5), 24.3, 27.7 (C-3), 36.7, 37.3 (C-2),
87.3, 88.9 (C-l).
Synthesis of D L-2-H ydroxy-3-m ethylpentanenitrile (142)
A solution of sodium cyanide (2.548 g, 0.052 mol) in water (5 ml) 
was added dropwise to a solution of 2-methylbutanal bisulfite 
addition product (4.934 g, 0.026 mol) in water (10.3 ml) at 0 °C 
After addition was complete the reaction mixture was stirred at 
room temperature for 2 h. The cyanohydrin was extracted from the 
aqueous solution with dichloromethane (5 x 20 ml), The combined 
organic extracts were dried over anhydrous MgSC>4 and filtered. The 
solvent was removed in vacuo to give the cyanohydrin as a 
colourless oil (2.497 g, 85%); Umax (thin film) 3445 (br O-H), 2970-
2880 (C-H), 2250 (w, CN), 1065 (C-O), and 1022 cn rl; 5 h  (200 MHz) 
0.94, 0.95 (3H, t, J 7.4 Hz, 5 -H3 ), 1.05, 1.06 (3H, d, J 3.3 Hz, 6 -H3), 
1.21-1.36 (2H, m, 4-H2), 1.57-1.81 (1H, m, 3-H), 2.86 (1H, s, OH), 
4.34, 4.37 (1H, d, J 3.2 Hz, 2-H); 8C 11.1, 11.2 (C-5), 14.1, 14.3 (C-6),
24.4, 24.8 (C-4), 39.3, 39.4 (C-3), 65.6, 65.9 (C-2), 119.2, 119.5 (C-l); 
m /z  87, 86, 71, 57, 29 (100%): (Found: M+-CN, 87.0777: C5H11O 
requires M-CN, 87.0765).
Form ation of DL-[6-2H3]-2 -H y d ro x y -3 -m eth y l-
p e n ta n e n itr i le
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The procedure was carried out as described for unlabelled 
material using [5-2H3]-2-methylbutanal in 79% yield, 5d 1.10.
Synthesis of D L -2-A m ino-3-m ethylpentanenitrile 
Hydrochloride (143)
The cyanohydrin (2.493 g, 0.022 mol) was added dropwise to 
concentrated aqueous ammonia (7 ml) in a conical flask, with 
stirring. The reaction mixture was stirred at room temperature for 6 
h, then the mixture was extracted with dichloromethane (5 x 30 ml). 
The combined organic extracts were extracted with 10% HC1 (4 x 50 
ml). The aqueous extracts were combined and the solvent was 
evaporated in vacuo to give the aminonitrile hydrochloride which 
was recrystallised from 95% ethanol (1.960 g, 60%); Umax (KBr disc)
3400 (br N-H), 2960-2880 (C-H), 2500, 2100 (+NH3) 2260 (CN), 
1450, and 1385 cn rl; 5H (200 MHz) (D2O ref HOD @ 4.64), 0.75 (3H, 
t, J 7.4 Hz, 5 -H3), 0.93, 0.92 (3H, d, J 6.7 Hz, 6 -H3 ), 1.28 (2H, m, 4-H2), 
1.88 (1H, m, 3-H), 4.26, 4.35 (1H, d, J 5.1 Hz, 2-H); 5C 11.1 (C-5), 14.4 
(C-6), 26.4 (C-4), 36.6 (C-3), 47.0 (C-2), 115.6 (C-l); m /z  112 (M+- 
HC1, 0.1%), 97, 83, 70, 57 (100%), 56; (Found M+-HC1, 112.0995: 
C^ H 12N2 requires M-HC1, 112.1000).
Formation of DI-[6-2H3] -2 -A m ino-3-m e th y  1-
pen tanen itrile  hydroch lo ride
The procedure was carried out as described for unlabelled 
material using DL-[6-2H3]-2-hydroxy-3-methylpentanenitrile in 61% 
yield, 5p (H20  ref HOD @ 4.63) 1.18.
Synthesis of DL-Isoleucine and  Allo-isoleucine 
Hydrochloride (144)
A solution of the aminonitrile hydrochloride (1.093 g, 7.36 mmol) 
in concentrated HC1 (5 ml) was allowed to stand at room temperature 
for 24 h. The reaction mixture was then heated at reflux 
temperature for 7 h and then allowed to cool to room temperature, 
at which point crystals began to form. On further cooling to 0 °C 
more crystals formed. The crystals were collected, washed with cold 
concentrated HC1 and dried to give the required DL-isoleucine 
hydrochloride. The filtrate and washings were combined and the 
solvent was removed in vacuo. The solid was extracted with hot 
ethanol and filtered. The ethanol was removed in vacuo. The 
isoleucine and allo-isoleucine hydrochloride were recrystallised from 
95% ethanol. (0.5792, 47%); umax (KBr disc) 3440 (br O-H), 2965- 
2880 (C-H), 1700 (C=0), ; 5H (200 MHz) (D20  ref HOD @ 4.63) 0.55 
(3H, t, J 7.3 Hz, 5 -H3), 0.62 (3H, d, J 7.0 Hz, 6 -H3 ), 0.80-1.15 (2H, m, 
4-H2), 1.60 (1H, m, 3-H), 3.27 (1H, d, J 3.9 Hz, 2-H); 5C 11.9, 12.2 (C- 
5), 15.5, 15.8 (C-6), 25.3, 25.5 (C-4), 36.7, 37.0 (C-3), 60.3, 60.6 (C-2), 
175.0, 175.3 (C-l); m /z  86, 69, 57, 28 (100%).
Formation of [6 -2 H3] Isoleucine and  A llo-isoleucine 
Hydrochloride (146)
The procedure was carried out as described above for unlabelled 
material using DL-[6-2H3]-2-amino-3-methylpentanenitrile 
hydrochloride in 46% yield, 5d  (H20) 0.70.
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8.3 Experimental for C hapter 4
Synthesis of 2-Butyl M ethanesulfonate (149)
A mixture of 2-butanol (30.5 ml, 24.67 g, 0.33 mol), and 
methanesulfonyl chloride (25.5 ml, 37.801 g, 0.33 mol) in THF (150 
ml) was cooled to -78 °C. Triethylamine (46 ml, 33.393 g, 0.33 mol) 
was added slowly. After addition was complete the mixture was left 
overnight to attain room temperature. The mixture was poured onto 
ice-water and then extracted with dichloromethane (3 x 75 ml). The 
organic extracts were dried, filtered and concentrated in vacuo. 
Distillation of the residue yielded the title compound as a colourless 
oil (45.012 g, 90%); b.p. 70 °C /  25 mmHg; t)max (thin film) 2970-
2880 (C-H), 1350, 1170 (0-S02), and 910 cn rl; 5H (200 MHz) 0.99 
(3H, t, 7.4 Hz, 4-H3), 1.42 (3H, d, J 6.3 Hz, I-H3), 1.70 (2H, m, 3-H2),
3.01 (3H, s, 5 -H3 ), 4.74 (1H, m, 2-H); 5c 9.4 (C-4), 20.6 (C-l), 29.5 (C- 
3), 38.4 (C-5), 81.6 (C-2); m /z  137, 123 (100%), 79, 59, 57; (Found 
M+-Me, 137.0231 : C4H9SO3 requires 137.0227).
Formation of [2-2 H]-2-Butyl M ethylsulfonate
The procedure was carried out as described above for unlabelled 
material but using [2-2H]butanol in 91% yield, 5 h  0.98 (3H, t, J 7.4 Hz, 
4 -H3), 1.40 (3H, s, I-H3 ), 1.70 (2H, m, 3-H2), 2.97 (3H, s, 5-H3); 5D 
4.76 (s, 2-D).
Synthesis of Dimethyl sec-B utylm alonate (150)
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To a suspension of NaH (95%, 1.895 g, 0.075 mol), in THF (60 ml) 
was added, dropwise with cooling, and under a nitrogen atmosphere, 
dimethyl malonate (8.44 ml, 9.702 g, 0.0735 mol) over a period of 
10 min. The mixture was stirred at room temperature for 1 h, then 
heated to 80 °C to bring the contents into solution. 2-Butyl 
methanesulfonate (11.172 g, 0.0735 mol) was added and the mixture 
was heated at reflux temperature for 44 h. The cooled mixture was 
distributed between water (100 ml) and ether (250 ml). The ether 
layer was washed with 100 ml portions of water until neutral. The 
solution was dried and concentrated under reduced pressure to give 
the diester. Distillation of the crude product yielded the desired 
compound as a colourless liquid (11.883 g, 8 6 %) b.p. 217 °C; Umax
(thin film) 2965-2880 (C-H), 1755, 1740 (C=0), 1265 (C-O), 1150, 
and 1130 cm-l; 5 h  (200 MHz) 0.91 (3H, t, J 7.3 Hz, CH3CH2), 0.97 (3H, 
d, J 6 .8  Hz, CH3CH), 1.15-1.53 (2H, m, CH2), 2.18 (1H, m, CH), 3.28 (1H, 
d, J 8.2 Hz, CH(G02Me)2), 3.73 (6 H, s, Me0 2 C); 5c 11.0 (CH3CH2), 16.3 
(CH3CH), 26.9 (CH2), 34.9 (CHMe), 52.0, 52.1 (2 x C O ^e), 57.0
(CH(C02Me)2), 169.1, 169.3 (2 x GC^Me); m /z  157, 132 (100%), 101, 
100, 74, 69, 59, 57; (Found M+-OMe, 157.0856: C8H13O3 requires 
157.0856).
Formation of [5-2 H]-Diethyl sec -b u ty lm a lo n a te
The procedure was as described above for unlabelled material but 
using [2-2H]-2-butyl methanesulfonate in 83% yield, 5 d  2.18 (s).
Synthesis of sec-Butylmalonic Acid (151)
The diester (6.166 g, 0.0328 mol), potassium hydroxide (6.081 g), 
and water (50 ml) were stirred at 70 °C for 4 h and then at room
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temperature overnight. The solution was concentrated to dryness at 
reduced pressure and the residue was washed with ether ( 1 0  ml) 
and then carefully acidified with ice cold 6 M HC1, keeping the 
temperature below 10 °C. The solution was extracted with ether ( 6  x 
15 ml), and the organic extracts were dried (MgSOq), filtered and 
concentrated in vacuo. On being kept overnight in a desiccator the 
malonic acid solidified as colourless crystals (4.089 g, 78%); m.p. 92 
°C (Ref. 93 °C); Umax (CHCI3 soln.) 3050 (br O-H), 3000-2920 (C-H), 
1700 (0=0), 1290, 1270 (C-O), and 930 cnrl; 5h (200 MHz) 0.92 (3H, 
t, J 7.3 Hz, CH3CH2), 1.04 (3H, d, J 6 .8  Hz, MeCH), 1.16-1.62 (2H, m, 
CH2), 2.19 (1H, m, CHMe), 3.36 (1H, d, J 7.6 Hz, CH(G02Me)2), 11.04 
(2H, br s, 2 x CO?H); 5C 11.2 (CH3CH?), 16.3 (CH3CH), 26.9 (CH?), 35.2 
(CHMe); 56.9 (CH(CO?Me)?), 174.7, 174.9 (2 x CO?H); m /z  160 (M+ 
4.6%), 114, 104 (100%), 98, 87, 69; (Found: M+ 160.0718; C, 52.75; H, 
7.39%: C7Hi? 0 4  requires M, 160.0700; C, 52.50, H 7.50%).
Formation of [4-2 H]-sec-Butyl Malonic Acid
The procedure was carried out as described for unlabelled 
material but using [5-2H]-diethyl sec-butylmalonate in 75% yield, 5p 
2.20 (s, CDMe).
Preparation of Hydrazoic Acid Solution
A three-neck flask was equipped with a dropping funnel, 
thermometer and a mechanical stirrer. Sodium azide (13 g, 0.2 mol) 
and water (13 ml) were added to the flask forming a paste. 
Chloroform (80 ml) was added and the mixture was cooled to 0 °C 
While the mixture was efficiently stirred and cooled concentrated 
sulfuric acid (11 ml) was added dropwise over 1 h. The temperature
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was maintained below 10 °C. After addition of sulfuric acid was 
complete the reaction was stirred at 0 °C for a further 1 h. The 
organic layer was then decanted and dried over anhydrous sodium 
sulfate. The hydrazoic acid solution was then titrated with standard 
sodium hydroxide solution.
A ttem pted Synthesis of Isoleucine and  Allo-isoleucine
A solution of the malonic acid (0.527 g, 3.3 mmol), in 100% (3 
ml), and CHCI3 (3 ml) was vigorously stirred while hydrazoic acid 
solution in CHCI3 (1.23 M, 2.85 ml, 3.5 mmol) was added dropwise 
over 1 h. The mixture was stirred at 55 °C for 2 h, and then for 
another 4 h at 25 °C. The CHCI3 layer was decanted and the acid 
layer was poured onto ice-water (15 ml) and washed with ether (3 x 
10 ml). Solid Ba(OH)2- 8 H2O (8  g) was added, bringing the pH to 2, 
the mixture was filtered through Celite and the precipitate was 
washed with water (40 ml). The combined filtrate and washings 
were concentrated in vacuo to yield a mixture of products containing 
a small amount of the required isoleucine and allo-isoleucine.
Synthesis o f Dimethyl 2 -B rom o-2-sec-buty lm alonate 
(152)
A three necked flask was fitted with a stirrer, dropping funnel 
and a reflux condenser with a tube leading to a flask of water for 
absorption of HBr. The flask was charged with dimethyl sec- 
butylmalonate (11.518 g, 0.061 mol) in dichloromethane (300 ml). 
Dry bromine (4.03 ml, 12.579 g, 0.08 mol) was placed in the 
dropping funnel. A few drops of bromine were added, with stirring. 
A large spotlight was shone on the flask until the reaction started.
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The remainder of the bromine was then added at such a rate as to 
keep the reaction mixture boiling gently. The reaction mixture was 
then heated at reflux temperature for 2 h. The mixture was cooled 
and washed with 5% Na2<D3 solution (5 x 200 ml). The organic layer 
was dried (MgSCU), filtered and the solvent was evaporated in vacuo 
(15.2265 g, 94%), u max (thin film) 2970-2880 (C-H), 1745 (C=0),
1250, 1210 (C-O), a n d  665 c n r l ;  5H (200 MHz) 0.97 (3H, t, J 7.2 Hz, 
CH3CH2), 1.07 (3H, d ,  J 6 .6  Hz, CH3CH), 1.41-1.75 (2H, m , CH2), 1 .6 8  
(1H, m, CH), 3.81 (6 H, s, 2 x C0 2 Me); 5C 12.2 (CH3CH2), 15.3 (CH3CH),
26.3 (C H 2), 42.2 (CH), 53.7 (2 x C02Me), 70.1 (C-Br), 167.1 (2  x 
CO2CH3); m /z  212, 210, 198, 196, 180, 179, 127; (Found: M+- Bu, 
211.9496, 209.9529 : requires 211.9507, 209.9527).
Synthesis o f 2-Brom o-2-sec-butylm alonic Acid (153)
The malonic acid (10.710 g, 66.9 mmol) was dissolved in ether 
(20 ml) and added to a 3-necked flask fitted with a reflux condenser 
and a dropping funnel. Bromine ( 5 x 1  ml) was added in portions. If 
the initial addition of bromine did not decolourise the solution the 
mixture was heated. The remainder of the bromine was added and 
the mixture was refluxed gently for 1 h. Water (20 ml) was added 
and the organic layer was separated. The solvent was removed in 
vacuo to give a yellow oil which crystallised overnight in a vacuum 
desiccator (12.77 g, 80%); Umax (KBr disc) 3400-2500 (br O-H), 2980- 
2880 (C-H), 1725 (C=0), 1385, 1265, 1240 (C-O), and 781 cn rl; 5h 
(200 MHz) (CD3OD ref @ 4.10) 0.76 (3H, t, J 7.3 Hz, CH3CH2), 0.87 (3H, 
d, J 6.5 Hz, 2 J3CH), 1.00-1.57 (2H, m, CH2), 1.98 (1H, m, CH); 5C 13.1 
(CH3CH2), 16.2 (CH3CH), 28.0 (CH2), 43.5 (CH), 73.5 (CBr), 170.2, 170.3 
(2 x C02 H); m /z  212, 210, 184, 182, 167, 166, 165, 164, 149, 147,
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140, 138 (100%); (Found: M+-Et , 211.9533, 209.9514: C5H7 0 4Br 
requires 211.9507, 209.9527).
Formation of [5-2H ]-2-B rom o-2-sec-butylm alonic acid
The procedure was carried out as described for unlabelled 
material but using [4-2H]-sec-butyl malonic acid in 77% yield, 5p
2.23 (s, CD).
Synthesis ofa-Brom o-(3-m ethylvaleric Acid (154)
The bromomalonic acid ( 9.602 g, 0.04 mol) was heated for 3 h at 
130 °C, after which time the title compound was separated from the
water formed and distilled to give a colourless oil (3.276 g, 42%); b.p. 
140 °C (20 mmHg); Umax (thin film) 3400-3000 (br O-H), 2970-2880 
(C-H), 1715 (C=0), 1203 (C-O), and 665 cnrl: 5H (200 MHz) 0.93 (3H, 
t, J 7.4 Hz, 5 -H3), 1.05 (3H, d, J 6.7 Hz, 6 -H3), 1.27-1.78 (2H, m, 4-H?),
2.04 (1H, m, 3-H), 4.18 (1H, d, J 6.2 Hz, 2-H), 11.23 (1H, br s, C02H); 
m /z  168, 166, 140, 138, 81, 79, 69, 57, 55, 41 (100 %), 28.
Synthesis of Isoleucine and  Allo-isoleucine 
Hydrochloride (144)
The a-bromo-(3-methylvaleric acid (2.071 g, 0.011 mol) was 
added to concentrated aqueous ammonia and stirred in a stoppered 
flask overnight. The aqueous solution was then concentrated in 
vacuo. The residue was taken up in ethanol and ethereal 
hydrochloric acid solution was added dropwise. The solvent was 
removed under reduced pressure and crude isoleucine and allo- 
isoleucine hydrochloride were recrystallised from hot water (0.9396
126
g, 51%), 3440 (br O-H), 2960-2880 (C-H), 2580 (H3N+), 1590 (C=0), 
1330, 1185 (C-O), and 540 cn rl; 5H (200 MHz) (D20  ref HOD @ 4.64)
0.80 (3H, t, J 7.3 Hz, 5 -H3), 1.02 (3H, d, J 7.0 Hz, 6 -H3), 1.05-1.40 (2H, 
m, 4-H2), 1.59 (1H, m, 3-H), 3.28 (1H, d, J 3.9 Hz, 2-H); 5C 11.6, 11.9 
(C-5), 15.3, 15.5 (C-6 ), 25.3, 25.4 (C-4), 36.4, 36.7 (C-3), 60.2, 60.3 (C- 
2), 174.7, 175.0 (C-l); m /z  8 6 , 69, 57, 28 (100%).
Form ation of DL-[3-2 H] Isoleucine and  A llo-isoleucine
H ydrochloride (146)
The procedure was carried out as described for the unlabelled 
material but using [5-2H]-2-bromo-2-sec-butylmalonic acid in 44% 
yield, 5d 1.63 (s, CD).
Feeding of [3-2 H]Isoleucine and  A llo-isoleucine
H ydrochloride
[3-2H]Isoleucine mixture (370 mg) was dissolved in distilled 
water and fed by the wick method method to three one-year-old 
Crotalaria lachnosema plants over 14 d. The plants were harvested 4 
d after feeding was complete and the standard alkaloid extraction 
procedure was followed.
General Conditions for Growth of Crotalaria lachnosem a
Seeds of Crotalaria lachnosema Stepf. were obtained from Dr. A. R. 
Mattocks. They were germinated in January and grown in a standard 
compost in 4” pots in a greenhouse. Feeding experiments were 
carried out with six-month-old plants for l^C-labelled precursors 
and plants more than a year old for 2H-labelled precursors.
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General Procedure for Alkaloid Extraction
After harvesting, the plants were macerated repeatedly in 
methanol. The methanolic extract was filtered and the solid residue 
was washed with methanol until the washings were colourless. The 
combined organic washings were concentrated in vacuo leaving a 
green residue. This residue was taken up in dichloromethane (20 ml) 
and extracted with 1M hydrochloric acid (2 x 20 ml). The combined 
acid extracts were washed with dichloromethane ( 6  x 2 0  ml) and 
then stirred at room temperature with zinc dust (2 g) for 2 h. The 
mixture was then filtered through Celite and basified with 
concentrated ammonia solution. The aqueous solution was extracted 
with dichloromethane (4 x 30 ml) and the combined organic extracts 
were dried (Na2SC>4 ), filtered and concentrated under reduced 
pressure to give the crude alkaloids which were purified by 
chromatography or crystallisation.
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8.4 Experimental for C hapter 5
Synthesis of Diethyl 2-E thylacetam idom alonate (158)
Ethyl iodide (0.38 ml, 0.756 g, 4.85 mmol) was added dropwise to 
a solution of sodium (0.110 g, 4.78 mmol) and diethyl 
acetamidomalonate (0.9440 g, 4.35 mmol) in absolute ethanol (20 
ml). After addition was complete the solution was heated at reflux 
temperature for 1 h. The mixture was then cooled to room 
temperature and the solution was decanted from the sediment. The 
ethanol was removed in vacuo. Recrystallisation of the crude product 
from 95% aqueous acetone gave the title compound as white crystals 
(0.878 g, 75%); Rf 0.53 (EtOAc); m.p. 82 °C (lit., 83°C); Umax (KBr disc)
3480-3300 (N-H), 2980-2880 (C-H), 1650 (N-HCO), 1760, 1745 (C=0), 
1520 (NHCO), 1245, 1200 (C-O), and 860 cm-l; 5H (200 MHz) 0.77 
(3H, t, J 7.6 Hz, CH3CH2C), 1.26 (6 H, t, J 7.1 Hz, CH3CH2O), 2.05 (3H, s, 
CH3CO), 2.36 (2H, q, J 7.6 Hz, CH2C), 4.25 (4H, q, J 7.1 Hz, CH20), 6.81 
(1H, s, NHCO); 5C 7.71 (CH3CH2C), 13.9 (CH3CH2O), 22.9 (CH3CO), 25.3 
(CH3CH2C), 62.3 (CH20), 67.0 (EtC), 160.1 (NHCO), 168.9 (2 x COzEt); 
m /z  245, (M+ 0.8%), 200, 172, 130 (100%), 102; (Found M+, 
245.1267; C, 53.38; H, 7.83; N, 5.78: C11H19NO5 requires M, 245.1263; 
C, 53.88; H, 7.76; N, 5.71).
Synthesis of Ethyl A cetam idocyanoacetate (160)
The procedure was carried out as described above but using 
acetamidocyanoacetate (69%); Rf 0.36 (EtOAc); m.p. 132°C; Umax
(nujol) 3440, 3410 (N-HCO), 2950 (C-H), 1755 (OC=0), 1700 (NHC=0), 
2250 (CN), 1230 (C-O), and 795 cm-l; 5H (200 MHz) 1.09 (3H, t, J 7.4
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Hz, GH3CH2C), 1.29 (3H, t, J 7.1 Hz, CH3CH2O), 1.99 (3H, s, CH3CO), 2.07 
(2H, q, J 7.4 Hz, CH?C), 4.26 (2H, dq, J 1.2 Hz, 7.1 Hz, CH20), 7.39 (1H, 
s, NHCO); 5c 7.9 (CH3CH2C), 13.3 (CH3CH2P), 21.1 (CONH), 29.3 (CH?C),
58.4 (CCH2), 62.8 (CH?0), 117.3 (CN), 166.6 (NHCO), 170.4 (CO?); m / z  
198 (M+ 0.6%), 153, 125, 111, 97, 83, 73, 43 (100%); (Found M+, 
198.000; C, 54.60; H, 7.16; N, 14.11: C9Hi4 N?03 requires M, 198.0996; 
C, 54.54; H, 7.67; N, 14.14).
Synthesis of 2-Am inobutanoic Acid H ydrochloride (161)
Diethyl 2-ethylacetamidomalonate (0.904 g, 3.69 mmol) was 
mixed with concentrated HC1 (35 ml, 37%) and heated at reflux 
temperature for 4 h. The reaction mixture was then cooled and 
concentrated in vacuo. The reaction mixture was washed with 
acetone, filtered and the filtrate was evaporated to dryness. 
Recrystallisation from 95% ethanol gave the desired amino acid 
hydrochloride as white crystals (0.407 g, 79%); m.p. >230 °C; Umax
(KBr disc) 3420 (br O-H), 3000 (br N-H), 1730 (C=0), 1210 (C-O), and 
780 cm-l; 5h (200 MHz) (D20  ref HOD @ 4.63) 0.82 (3H, t, J 7.5 Hz, 4- 
H3), 1.78 (2H, m, 3-H?), 3.79 (1H, t, J 6.0 Hz, 2-H), 5C 9.3 (C-4), 24.0 
(C-3), 54.8 (C-2), 173.0 (C-l); m /z  74, 58 (100%); (Found: C, 34.25; H, 
7.03; N, 10.10: C4Hi0 NO2C1 requires: C, 34.41; H, 7.17; N, 10.04).
Formation of [3,4-2 Hs]-2-Am inobutanoic acid (162)
The procedure was carried out as previously described but using 
ds-iodoethane. 5p (H?0) 1.20 (3D, br s, CD3 ), 2.16 (2D, br s, CD?).
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Formation of [3,4-13C2]-2-Am inobutanoic acid (163)
The procedure was repeated as described above but with 13C2- 
iodoethane fiH (200 MHz) (0.81 (3H, dm, J 130Hz, 13CH3), 1.76 (2H, 
dm, J 130 Hz, 13CH2), 3.76 (1H, m, CH); 5c 9.3 (d, J 34 Hz, l3CH3- 
13CH2), 24.2 (d, J 34 Hz, 13 CH?-13CH3).
Feeding Experim ents w ith 2-Am inobutanoic Acid 
H ydrochloride
1. Senecio pleistocephalus S. Moore;
Plants were obtained from the Royal Botanic Gardens, Edinburgh, 
and were propagated by stem cuttings and grown in 5" pots in a 
standard compost in a greenhouse. The labelled amino acids were 
dissolved in distilled water and fed by the wick method.
(i) [3,4-l3C?]-2-Aminobutanoic acid (11 mg) was fed to three six 
month old plants over 4 d. After a further 10 d rosmarinine was 
extracted, using the standard alkaloid extraction procedure, and 
recrystallised (DCM: Acetone; 1:1).
(ii) [3,4-2H5]-2-Aminobutanoic acid (150 mg) was fed to two well 
established plants over 10 d. After a further 5 d the plants were 
harvested and, using standard methods the alkaloid sample was 
extracted. The rosmarinine obtained was purified by 
recrystallisation; m.p. 205-207°C (lit. 202-204°C).
2. Crotalaria lachnosema
The labelled amino acids were fed by the wick method as 
solutions in distilled water.
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(i) [3,4-13C2]-2-Aminobutanoic acid (20 mg) was fed over 4 d to 
eight six month old plants. The plants were harvested after a further 
6  d. Extraction was by the normal procedure.
(ii) [3,4-2Hs]-2-Aminobutanoic acid (150 mg) was fed over 14 d to 
one large plant. After a further 4 d the C. lachnosema plant was 
harvested and the standard alkaloid procedure was followed.
Establishm ent and Propagation of Root Cultures
Hairy root cultures of Emilia flammea Cass, and Senecio vulgaris L. 
transformed with Agrobacterium rhizogenes were established as 
described. 115 These cultures, provided by Dr. N Walton at the A.F.R.C. 
Food Research Institute, Norwich, were grown on Gamborgs B5 basal 
medium with 80 mM of sucrose added, with a 90 r.p.m. shake rate.
Feeding of 2-Am inobutanoic Acid Hydrochloride to 
Transform ed Root Cultures
L Senecio vulgaris
(i) [3 ,4 -2H5]-2 -Aminobutanoic acid (150 mg) was dissolved 
in sterile water (1  ml) and divided among 1 0  flasks each containing 
seven day old roots. The flasks were shaken for a further 14 d 
before the cultures were drained and the roots were blended in 
methanol.
(ii) [3 ,4 -15C2]-2 -Aminobutanoic acid (15 mg) was dissolved 
in sterile water and divided among 1 0  flasks containing six day old 
roots. After a further 14 d the cultures were drained and the roots 
blended in methanol.
The standard alkaloid procedure was followed and senecionine 
isolated.
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2. Emilia flammea
(i) [3,4-2Hs]-2-Aminobutanoic acid (150 mg) was dissolved 
in sterile water and divided among 1 0  flasks containing seven day 
old roots. After a further 15 d shaking, the cultures were harvested.
(ii) The above feeding experiment was repeated and the 
cultures were harvested after a total of 26 d.
(iii) [3,4-13C2]-2-Aminobutanoic acid (15 mg) was dissolved 
in sterile water and divided among 1 0  flasks, each containing seven 
day old roots. After a further 14 d shaking the cultures were drained 
and the roots blended in methanol.
The standard alkaloid procedure was then followed.
I am grateful to Isabel Freer for the preparation and maintenance 
of the root cultures and for carrying out the feeding experiments to 
these root cultures.
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8.5 Experimental for C hapter 6
Preparation o f 13-O-A cetyldicrotaline (18)
The alkaloid extract from C. lachnosema was shown to be a 
mixture of dicrotaline and the minor product 13-Oacetyldicrotaline. 
For ease of analysis this mixture was converted into solely 13-O­
acetyldicrotaline. The mixture was dissolved in acetic anhydride (5 
ml) and acetyl chloride (5 ml) was added. The reaction mixture was 
heated at reflux temperature for 2  h, then the solvent was removed 
in vacuo. The residue was taken up in dichloromethane (20 ml) and 
extracted with 1M HC1 (2 x 20 ml). The acidic layer was basified with 
conc. aqueous ammonia and extracted with dichlorome thane ( 6  x 2 0  
ml). The combined organic layers were dried, filtered and the 
solvent removed in vacuo to give 13-Oacetyldicrotaline as an oil 5H 
(200 MHz) 1.72 (3H, d, J 0.8 Hz, 13-Me), 2.00 (3H, s, 13-O-Ac), 2.07 
(2H, m, 6 a, 60), 2.41 (1H, d, J 15.6 Hz 12-pro-S), 2.55 (1H, dm, J 8.9 
Hz, 50), 2.78 (1H, dq, J 13.4, 0.8 Hz, 14-pro-S), 2.93 (1H, dd, J 13.4,
1.2 Hz„ 14-pro-R), 3.26 (1H, dd, J 15.6, 1.2 Hz, 12-pro-R), 3.28 (1H, 
dm, J 8.9 Hz, 5a), 3.40 (1H, ddt, J 15.8, 2.1, 5.6, 1.7 Hz, 30), 3.88 (1H, 
dtd, J 4.4, 5.5 Hz, 3a), 4.09 (1H, ddq, J 12.2, 1.5, 1.2, 3.9, 1.7 Hz, 9- 
pro-R), 4.30 (1H, br m, H-8 ), 5.16 (1H, dt, J 4.4, 5.0 Hz, H-7), 5.31 (1H, 
d, J 12.2 Hz, 9-pro-5), 5.90 (1H, quin, J 2.0, 2.1, 1.6, 1.5 Hz, H-2); 5c
22.3 (13-O-Ac), 26.1 (13-Me), 34.0 (6 a, 60), 41.3 (C-12), 43.7 (C-14), 
53.7 (C-5), 60.2 (C-9), 61.9 (C-3), 75.1 (C-7), 77.0 (C-8 ), 79.5 (C-13), 
131.4 (C-2), 132.5 (C-l), 168.7 (C-ll), 169.5 (C-15), 170.2 (13-OCO).
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8.6 Experim ental fo r C hap ter 7
Synthesis of D iethyl 2 -M ethy lam inosuccinate  (169)
Methylamine in ethanol (33%, 30 .8  ml, 0 .3 0  mol) was added, 
in portions at 0°C to diethyl maleate (4 4 .1 3 0  g, 0 .2 5 7  mol) with 
occasional stirring and ice-bath cooling. After addition was 
complete, the flask was stoppered and kept in the ice-bath for a 
further 30  min then the mixture was allowed to stand at room 
tem perature for 48  h. The ethanol was then  removed under 
reduced pressure and the colourless residue was dissolved in 
sufficient 4M HC1 to give an acidic solution. This acidic solution 
was washed with hexane (3 x 150  ml), basified with 
concentrated ammonia and extracted with dichlorom ethane (3 x 
150 ml). The combined extracts were dried, filtered and 
concentrated in vacuo to give the title com pound as a colourless 
oil (42 .258  g, 81%), b.p. 60  °C (0.6 mmHg); l)max (thin film) 3 3 4 0
(N-H), 2980 (C-H), 2800 (N-Me), 1730 (C=0), 1180 (C-O), ; 5H 
(200 MHz) 1.26 (3H, t, J 7.1 Hz, CO2CH2CH3), 1.29 (3H, t, J 7.1 Hz, 
CD2CH2CH3), 2.42 (3H, s, NMe), 2.68 (2 H, ddd, J 10.4, 6 .2 . 6.9 Hz. 
CH2CH), 3.55 (1H, dd, J 6.9, 6.2 Hz, CH), 4.15 (2H, q, J 7.1 Hz, 
GOCH2), 4.22 (2 H, q, J 7.1 Hz, COCH2); 5c 14.0, 14.1 (2 x 
(D2CH2CH3), 34.9 (NMe), 37.5 (CH2CH), 59.2 (CH), 60.5, 60.8 (2 x 
CD2CH2), 170.7, 173.3 (2  x CO2); m /z  203 (M+, 0 .6 %), 158, 130 
(100%), 116, 84, 29, 28; (Found: M+ 203.1151: CgHiyNDq requires 
M, 203.1158).
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Synthesis of D iethyl (N -E th o x y ca rb o n y lm e th y l)-2 - 
m eth y lam in e  (170)
Ethyl bromoacetate (6.37 ml, 58.1 mmol) was added to a 
mixture of diethyl 2-methylaminosuccinate (11.4317 g, 56.2 
mmol) and anhydrous potassium carbonate (11.6 g, 84.3 mmol) 
in aqueous acetone (7% H2O) (45 ml). The mixture was heated at 
reflux tem perature for 24 h, filtered and  the filtrate was 
concentrated in vacuo. The oily residue was dissolved in 
sufficient 2 M HC1 to give an acidic solution. The acidic solution 
was washed with ether (3 x 10 ml), basified with concentrated 
ammonia solution and extracted with ether (3 x 15 ml). The 
combined extracts were dried, filtered and concentrated under 
reduced pressure to give the desired product (11.894 g, 73%), 
b.p. 115 °C (0.2 mmHg); Umax 2980 (C-H), 2800 (NMe), 1730
(0=0), 1180 (C-O), 1030 cm-l; 5H (200 MHz) 1.25, 1.27, 1.30 (9H, 
t, J 7.1 Hz, 3 x CO2CH2CH3), 2.44 (3H, s, NMe), 2.76 (2H, ddd, J 
16.1, 9.0, 5.9 Hz, CH2CH), 3.43 (2H, s, NCH2), 3.86 (1H, dd, J 9.0, 
5.9 Hz, CH), 4.22 (6 H, m, 3 x CO2CH2); 5c 14.0, 14.1, 14.2 (3 x 
CD2CH2CH3), 35.6 (ODCH), 38.9 (NMe), 56.0 (NCH2), 60.4, 60.5,
60.6 (3 x CO2CH2), 62.4 (CH), 170.6, 170.7, 170.9 (3 x C0 2); m /z  
289 (M+ 4.8%), 216 (100 %), 202, 170, 142, 70; (Found: M+, 
289.1524: C13H23NOG requires M, 289.1525).
S yn thesis o f D iethy l l-M eth y l-4 -o x o p y rro lid in e -2 ,3 - 
d ica rb o x y la te  (171)
The triester (3.538 g, 12.5 mmol) in dry  benzene (25 ml) was 
stirred with sodium hydride (oil free, 95%, 0.336 g, 12.9 mmol)
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at room tem perature, under a nitrogen atmosphere. After 5 h 
the reaction m ixture was extracted with w ater (3 x 20 ml). The 
aqueous extracts were combined, washed with diethyl ether (3 x 
20 ml) and acidified with concentrated HC1, with ice cooling, to 
pH 1. The acidic solution was washed with ether (3 x 30 ml) and 
then the pH adjusted to 6  with concentrated aqueous ammonia 
solution. The combined organic extracts were dried, filtered and 
concentrated in vacuo to give the title com pound as a colourless 
oil (1.869 g, 62 %); Umax (thin film) 2980 (C-H), 2790 (NMe),
1770 (C=0), 1730 (OC=0), 1200 (C-O), and 1030 c u r 1 ; 5 H (200 
MHz) 1.28 (6 H, t, J 7.2 Hz, 2 x CO2CH2CH3), 2.54 (3H, s, NMe), 3.02 
(1H, d, J 17.0 Hz, NCHa), 3.59 (1 H, d, J 17.0 Hz, NCHr), 3.60 ( 1H, d, 
J 9 Hz, NCH), 3.85 (1H, d, J 9,0 Hz, CHCO), 4.24 (4H, q, J 7.2 Hz, 2 x 
CD2CH2); 5 c  14.1 (2 x CO2CH2CH3 ), 40.7 (NMe), 58.6 (NCH), 61.6,
62.1 (OCH2 ), 62.5 (NCH2), 67.6 (CHCO), 166.2, 170.2 (CQ2EO, 203.7 
(COCH2); m /z  243 (M+ 1.5 %), 198, 170, 142, 124, 98, 29 (100 %); 
(Found: M+, 243.1108: C11H17NO5 requires M, 243.1107).
S yn thesis o f D iethy l 4 -H y d ro x y -1 -m e th y lp y rro lid in e-
2 ,3 -d ica rb o x y la te  (172)
A solution of sodium borohydride (0.381 g, 0.44 mmol) in 
water (0.5 ml) was added to an ice-cold solution of the crude 
pyrrolidone (0.2155 g, 0.88 mmol) in aqueous sodium hydroxide 
(2%) (1.6 ml). The mixture was stirred at 0 °C for 1.5 h, and then 
carefully acidified with 2M HC1. The acidic solution was washed 
with ether ( 3 x 5  ml), then basified with concentrated ammonia 
solution. The aqueous layer was then extracted with ether ( 3 x 5  
ml). The combined organic extracts were dried, filtered and
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concentrated in vacuo, to give title com pound as an oil (70 mg, 
65%); Umax 3450 (O-H), 2980 (C-H), 2800 (NMe), 1770, 1730
(C=0), 1205, 1180 (C-O), and 1030 cm-l; 5H (200 MHz) 1.23-1.35 
(6H, m, 2 XCO2CH2CH3), 2.44 (3H, s, NMe), 2.50-3.65 (6H, m, 2-H, 
3-H, 4-H, 5-H2, OH), 4.14-4.39 (4H, m, 2 x CO2CH2CH3); &C 14.0 (2 
XCH2CH3), 39.5, 40.6, 41.0 (NMe), 53.1, 53.6, 57.8 (CHOH), 61.3 (2 
x CO2CH2), 63.2, 63.6, 63.8 (NCH2), 66.5, 67.8, 69.0 (CHCHOH),
70.5, 71.9, 73.8 (CHN), 172.0 (2 x CO?Et); m /z  247 (M+ 0.1 %), 
245, 172 (100 %), 144, 126, 82; (Found M+-H2, 245.1268: 
C11H19NO5 requires M-H2 , 245.1263).
Synthesis o f D iethy l 1-M eth y l-3 -p y rro lin e -2 ,3- 
d icarboxy la te  (173)
A solution of p-toluenesulfonyl chloride (8.20 g, 0.44 mol), in 
dry pyridine (13 ml), was added to a  solution of the 
hydroxypyrroline (2.729 g, 0.11 mol) in pyridine ( 6  ml). The 
mixture was heated on a  steam bath in a  stoppered flask for 2  h, 
after which time the solvent was rem oved under reduced 
pressure. The residue was dissolved in sufficient ice-cold 2M HC1 
to give an acidic suspension. The suspension was washed with 
ether (4 x 25 ml), basified with concentrated ammonia solution, 
and extracted with ether (3 x 65 ml). The combined organic 
extracts were dried, filtered and concentrated in vacuo to give a 
dark red oil. The oil was azeotroped with water (3 x 10 ml) and 
then benzene (3 x 10 ml) to remove any residual pyridine. The 
product was then redissolved in ether, dried, filtered and 
concentrated under reduced pressure to give the desired product 
as dark red oil (0.998 g, 40%); u max (CHCI3 soln) 3020 (C=C-H),
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2980 (C-H), 2800 (NMe), 1730 (C=0), 1645 (C=C), 1280, 1215 (C- 
O), 1035, and 980 cm-l; 5H (200 MHz) 1.26, 1.27 (6 H, t, J 7.1 Hz, 2 
XCO2CH2CH3), 2.59 (3H, s, NMe), 3.52 (2H, ddd, J 16.6, 4.4, 2.1 Hz, 
NCH2), 4.01 (1H, ddd, J 16.6, 5.4, 2.1, Hz, NCH2) 4.11-4.26 (5H, m, 
2 -H and 2 x CCbCH?), 6 .8 8  (1H, m, C=CH); 5C 14.1, 14.2, (2 x 
(D2CH2CH3), 40.9 (NMe), 60.6, 61.0 ( 2  x CO2CH2), 62.0 (NCH2), 
73.0 (NCH2CD2), 133.2 (C=CH), 141.7 (CH=C), 162.7 (CHCQ?Et),
171.3 (CH=C-G02Et); m /z  227 (M+ 1.5 %), 180, 154, 126, 108, 82 
(100 %); (Found: 227.1148; C11H17NO4  requires M+, 227.1158).
Syn thesis o f 2 ,3 -bis (H y d ro x y m e th y l)- l-m e th y l-3  -
p y rro lin e  (Syn thanecine A) (19)
A solution of DIBAL in dichlorom ethane (1.0M, 33.5 ml, 33.5 
mmol) was added, with stirring and cooling to 20-25 °C, over 30 
min to a solution of the diester (0.710 g, 2.8 mmol) in dry  
toluene (5 ml) under argon. The reaction mixture was stirred at 
room temperature for 1 h. Ethyl acetate (5 ml) was then added 
to consume the excess DIBAL. After a fu rther 5 m in acetone (11 
ml) followed by Celite (2.2 g) were added. Methanol was then 
added slowly and with cooling. The mixture was shaken 
vigorously until gelling occurred (5 min), then water (22 ml) was 
added. The mixture was shaken vigorously again to break up the 
gel, then stirred at room  tem perature for 1.5 h. The resulting 
suspension was filtered, and the solid residue was washed, 
firstly with hot water ( 2  x 1 0  ml) then  w ith hot m ethanol ( 2  x 1 0  
ml). The combined filtrates were concentrated under reduced 
pressure, and then azeotroped with benzene ( 4 x 5  ml). Finally a
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solution of the product in chloroform was dried, filtered and 
concentrated under reduced pressure to give the title compound 
as a thick oil (0.151 g, 42 %); Umax (CHCI3 ) 3380 (br, O-H) 3020
(C=C-H), 2975- 2880 (C-H), 2800 (NMe), 1215 (C-O), and 1010 
cm-1; 5 H (200 MHz) 2.33 (3H, s, NMe), 3.08 (1H, m, 5-H), 3.36 
(1H, m, 2-H), 3.55 (2H, m, 6 -H2), 4.03 (2H, b r s, 7-H2), 4.65 (2H, 
br s, 2 x OH), 5.62 (1H, b r s, 7-H?); 5 C 41.0 (NMe), 59.1 (C-6 ), 61.0 
(C-5 and C-7), 73.8 (C-2), 124.0 (C-4), 141.7 (C-3); m /z  143 (M+,
0.9%), 141, 112, 94, 82 (100%), 67, 59, 57; (Found: M+, 143.0936; 
C7H13NO? requires 143.0946).
S ynthesis o f 2 ,3 -b is (H y d ro x y m e th y l)- l-m e th y l-  
p y rro lid in e  (S yn thanec ine  B) (20)
The pyrroline (0.736 g, 3.24 mmol) and lithium aluminium 
hydride (1.49 g) in ether (28 ml) were heated at reflux 
temperature for 1 h. 1M NaOH solution was added to the cooled 
mixture. The e ther layer was decanted and the wet solids were 
stirred with hot ethanol. Chloroform (5 ml) and Celite (1.5 g) 
were added and the mixture was filtered. The filtrate was 
concentrated to an oil which was re-extracted with hot 
chloroform. This extract was combined with the original ether 
layer and the com bined organic layers were dried, filtered, and 
the solvent was evaporated in vacuo to give synthanecine B as a 
thick oil (282 mg, 60 %), u max (CHCI3) 3380 (br, O-H), 2950-2880
(C-H), 2795 (NMe), 1220-1210 (C-O), and 1035 cm-l; 5 H (200 
MHz) 2.35 (3H, s, NMe), 2.12-2.51 (3H, m, 3-H, 4-H2), 3.39-3.90 
(7H, m, 6 -H?, 7-H?, 2-H, 5-H), 4.90 (2H, br s, 2 x OH); 5 c  26.0 (C- 
4), 40.5, 40.9 (NMe), 44.5 (C-3), 72.1, 73.5 (C-2), 55.7, 56.0 (C-5),
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59.3, 60.5 (C-7), 60.9, 61.7 (C-6 ); m /z  111, 97, 85, 71, 57 (100
%).
Feeding of S yn thanecine A an d  S ynthanecine B to  
Senecio  vulgaris
(i) Synthanecine A (150 mg) was dissolved in distilled 
water and divided among 1 0  flasks containing seven day old 
roots. The roots were shaken for a fu rther 14 d before the 
cultures were drained and the roots were blended in methanol.
(ii) Synthanecine B (150 mg) was fed as described above.
Root culture preparation was as previously described. Once 
again thanks are due to Isabel Freer for carrying out this part of 
the work. The standard alkaloid procedure was then followed. 
Senecionine (20-30 mg) was isolated in both  cases.
A ttem p ted  S yn thesis o f 3 -H y d ro x y m eth y l-l-  
m e th y lp y rro lid in e  (183)
Trimethylamine JV-oxide (0.400 g, 5.29 mmol) was heated 
under vacuum at 40 °C for 2 h. THF (50 ml) and allyl alcohol 
(0.36 ml, 307 mg, 5.29 mmol) were added and the tem perature 
was lowered to -78 °C for 4 h. Excess LDA was quenched with 
water (20 ml). The layers were separated and the aqueous layer 
was extracted with ether (2 x 20 ml). The combined organic 
layers were extracted with 1M HC1 (2 x 30 ml). The acidic layers 
were basified with concentrated aqueous am m onia and extracted
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with dichloromethane ( 3 x 5 0  ml). The organic layers were dried, 
filtered and the solvent was evaporated. No pyrrolidine was 
observed and the starting m aterial could no t be recovered. The 
reaction was repeated at 0 °C and with stirring continued up to 
18 h.
A ttem pted  S yn thesis o f D im ethy l 1-M ethyl-3 - 
p y r ro lin e -3 ,4 -d ic a rb o x y la te
The procedure was carried out as described above except that 
dimethyl acetylenedicarboxylate was used. The reaction was 
attem pted at 0 °C and -78 °C and with stirring for up to 6  h. No 
pyrroline was observed and the product was a  dark brown oil 
which was a mixture of materials.
A ttem pted  S yn thesis o f D iethy l 1 -M ethy lpy rro lid ine- 
3 ,4 -d ic a rb o x y la te
The procedure was carried out as before but using diethyl 
fumarate and diethyl maleate at 0 °C and -78 °C. The reaction 
was stirred for up to 2 0  h  bu t a  m ixture of products were 
obtained as a brown oil. There was no pyrrolidine present.
A ttem pted  S yn thesis o f 3 -H y d ro x y m eth y l-l-  
m e th y lp y rro lin e  (184)
The reaction procedure was carried out as previously 
described but using propargyl alcohol. With a  tem perature of 
-78 °C and stirring for 4 h there was no pyrroline detected. A
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dark oil was obtained and no starting m aterial could be 
recovered.
A ttem pted  S yn thesis o f 1-M ethyl-4 ,5 ,6 ,7-
te tra h y d ro d io x e p in p y rro lid in e  (186)
The procedure was carried out as before except with cis-4,7- 
dihydro-l,3-dioxepin at 0 °C and -78 °C and stirring for 4 h. No 
pyrrolidine was observed and the starting m aterial could no t be 
recovered.
Synthesis o f N -B e n z y l-N -(tr im e th y ls ily lm e th y l)-  
am inom ethy l m eth y l E ther (188)
To a solution of formalin and methanol (0.092 ml. 0.073 g, 
2.28 mmol) was added N-(trimethylsilylmethyl)benzylamine 
(0.366 g, 1.90 mmol) dropwise at 0 °C. The mixture was then 
stirred for an additional 3 h. Potassium carbonate was added and 
the oily layer was separated. The residue was washed with ether 
and the combined organic layers were dried over anhydrous 
potassium carbonate. Filtration and solvent evaporation gave the 
title compound as a  colourless liquid (0.3762 g, 84 %); b.p. 77 °C 
Umax 3030 (Ar C-H), 2950 (C-H), 2840 (O-CH3), 1500 (Ar C-C), 
1250 (Me3Si), 1070 (C-OC), 850 (Me3Si), 740, and 700 cnr*; 5h 
(200 MHz) 0.00 (9H, s, Me3Si), 2.11 (2H, s, SiCH2), 3.18 (3H, s, 
OCH3), 3.71 (2H, s, OCH2), 3.95 (2H, s, CH2Ph), 7.12 (5H, m, Ph); 5C 
-1.44 (Me3Si) 42.6 (SiCH2), 55.3 (OCH3), 59.5 (OCH2), 88.4 
(CH2PI1), 126.8, 128.0, 128.7 (CH), 139.7 (C); m /z  237 (M+ 0.5 %),
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222, 206, 192, 164, 134, 116, 91, 89, 77, 30 (100 %); (Found: M+ 
237.1537; C13H23NOSi requires M, 237.1526).
Synthesis of D iethy l l-B en zy lp y rro lid in e -3 ,4 - 
d icarb o x y la te  (192)
Caesium fluoride (84 mg, 0.55 mmol) was heated under 
vacuum at 40°C for 2 h, then THF (10 ml), aminomethyl methyl 
ether (647 mg, 2.73 mmol) and diethyl fum arate (470 mg, 2.73 
mmol) were added, under a nitrogen atmosphere. To this 
solution, trimethylsilyl triflate (109 mg, 0.55 mmol) was added 
and the reaction mixture was stirred at 60 °C for 18 h. The flask 
was cooled to 0 °C and 15% NaOH (10 ml) added. The organic 
layer was separated and the aqueous phase was extracted with 
ether (3 x 10 ml). The combined organic layers were dried 
(K2CD3), filtered and the solvent was rem oved under reduced 
pressure. The pyrrolidine was isolated as an  oil by preparative 
TLC (84%); Rf 0.85 (Et?0) Dmax 3020 (ArC-H), 2980-2800 (C-H),
1730 (C=0), 1300, 1220 (C-O), and 740 cm"1; 5H (200 MHz) 1.18 
(6 H, t, J 7.2 Hz, 2 x CH3 ), 2.78 (4H, m, NCH2), 3.39 (2H, m, 2 x 
CHCH?), 3.54 (2H, s, PhCH?), 4.09 (4H, q, J 7.2 Hz, 2 x CO?CH?),
7.23 (5H, m, Ph); 5C 14.1 (2 x CH3), 45.4 (2 x CBOO?), 56.5 (2 x 
CH?CH), 59.3 (NCH2), 60.9 (2 x CO?CH2), 127.0, 128.2, 128.5 (Ar 
CH), 138.3 (CCH?), 173.5 (2 x CC^Et); 5c 14.1 (CH3), 45.4 (CH?),
56.5 (CH2CH), 59.3 (NCH?), 60.9 (CO?CH?), 127.0, 128.2, 128.5 (C- 
H), 138.3 (CCH?), 173.5 (2 x CO?); m /z  305 (M+ 2.2%), 276, 260, 
228, 214, 168, 140, 91 100%), 77; (Found: M+ 305.1626; 
C17H73NO4  requires M, 305.1626).
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Synthesis o f D im ethy l 1-B en zy l-3 -p y rro lin e-3 ,4- 
d icarboxy la te  (191)
The procedure described above was carried out using caesium 
fluoride (0.2580 g, 1.7 mmol), dimethyl acetylene dicarboxylate 
(0.98 ml, 1.137g, 8 mmol), aminomethyl m ethylether (1.896 g, 8 
mmol), and trimethylsilyl triflate (0.328 ml, 0.334 g, 0.17 mmol), 
and the mixture was heated a t 55 °C for 20 h  to give the title 
compound as a colourless oil (61 %); o max 3020 (C-H), 2960 (C-
H), 1735 (C=0), 1725 (C=0), 1600, 1580, 1500 (Ar C-C), 1270, 
1210 (C-O), and 780 cm-l; 5 h  (200 MHz) 3.79 (6H, s, 2 x CH3), 
3.81 (2H, s, PhCH2), 3.92 (4H, s, 2 x CH2C), 7.33 (5H, m, CH); 5C
52.2 (CH3), 59.7 (PhCH2), 60.6 (CH2C), 127.3, 128.5, 128.6 (CH),
137.1 (C-C), 138.4 (ArC), 164.0 (2 x C 02); m /z  275 (M+ 3.5%), 
243, 184, 157, 91 (100%), 77; (Found: 275.1166; C15H17NO4  
requires M, 275.1158).
Syn thesis o f 3 ,4 -b is -(H y d ro x y m e th y l)- l-
b en z y lp y rro lid in e  (193)
The diester (228 mg, 0.748 mmol) was dissolved in  dry 
toluene (5 ml) in a three-necked flask under a nitrogen 
atmosphere. A solution of DIBAL (1.0M in toluene, 90 ml, 9.0 
mmol) was added over 10 min, with stirring and cooling in an 
ice-bath. After addition was complete the reaction m ixture was 
stirred at room tem perature for 1 h. Ethyl acetate (2 ml) was 
added to consume the excess DIBAL, followed after 5 m in by 
acetone (10 ml) and Celite (2 g). Methanol (2 ml) was then 
added, slowly and with cooling. The m ixture was then shaken
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vigorously until gelling occurred (5 min), before water (20 ml) 
was added, to break up the gel, and the mixture was stirred for
1.5 h. The suspension was then filtered and the solid residue was 
washed with hot water ( 2  x 1 0  ml) then hot m ethanol ( 2  x 1 0  
ml). The combined filtrates were concentrated in vacuo. The 
crude product was extracted with chloroform ( 1 0  ml), dried, 
filtered and concentrated to give the desired product which was 
recrystallised from dichlorom ethane/ acetone (1:1) (70 mg, 70 
%); m.p. 82 °C; Omax (CHCI3) 3350 (br, O-H), 3020 (Ar C-H), 2955-
2870 (C-H), 1600, 1580 (Ar C-C), 1220, 1215, 1213 (C-O), and 
760 cm-l; 5H (200 MHz) 2.15 (2H, m, 2 x CHCH2), 2.30 (2H, dd, J
8.5, 5.6 Hz, CHCH2OH), 2.72 (2H, dd, J 9.0, 7.3 Hz, CH2CH), 3.54 
(4H, m, 2 x CH?OH), 3.55 (2H, s, PhCH2), 3.81 (2H, br s, 2 x OH), 
7.27 (5H, m, Ph); 5c 44.6 (CHCH?), 57.1 (NCH2CH), 60.2 (PhCH?),
65.7 (CH2OH), 127.1, 128.3, 128.8 (Ar CH), 138.3 (Ar C); m  /  z  
221 (M+ 3.4%), 202, 191, 144, 130, 112, 91 (100%), 77; (Found: 
221.1403; C13H19NQ? requires M, 221.1416).
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